?

Discussions and Knowledge Gaps

1

Does an autoimmune response to pituitary and hypothalamic antigens released by the infarcted gland actively perpetuate and extend hormone loss in Sheehan syndrome, or are anti-pituitary and anti-hypothalamus antibodies a non-causal marker of the necrosis that has already occurred?

KNOWLEDGE GAP OPEN sheehan-autoimmune-perpetuation

Attached to

pathophysiology#Ischaemic Infarction and Necrosis of the Anterior Pituitary pathophysiology#Loss of Anterior Pituitary Trophic Hormone Secretion

Hormone deficiencies accumulate for years to decades after a single peripartum vascular insult, and a secondary autoimmune process against antigens released by the necrotic gland is the leading proposed explanation. Anti-pituitary antibodies are found in roughly a third of long-standing cases and anti-hypothalamus antibodies in about 40%, but these are cross-sectional associations in small cohorts with no demonstration that the antibodies precede the additional hormone loss or are pathogenic. Because the evidence does not establish direction, this entry does not draw a causal edge from autoimmunity to progressive hormone loss; the autoimmune contribution is recorded here as an open question instead. Resolving it matters clinically: if the process is active and antibody-mediated, antibody status might identify patients whose remaining axes are at risk, which nothing in current practice does.

Show evidence (6 references)

PMID:18230820 SUPPORT Human Clinical

"AHAs were found in 8 out of 20 (40%) and APAs in 7 out of 20 (35%) patients with titers ranging from 1:32 to 1:128 and 1:16 to 1:32 respectively; however, in none of these positive patients AHA immunostained vasopressin cells."

Establishes that the antibodies are present in a substantial minority of patients, which is the observation the open question is about.

PMID:18230820 SUPPORT INDIRECT Human Clinical

"Antibodies to unknown hypothalamic cells (releasing factor-secreting cells) other than APAs suggest that an autoimmune process involving both the hypothalamus and pituitary gland may contribute to late pituitary dysfunction in SS patients."

The authors themselves phrase the causal contribution as a suggestion inferred from an association, not a demonstrated mechanism, which is why this is curated as a knowledge gap rather than a causal edge.

PMID:28004764 SUPPORT INDIRECT Other

"Small sella turcica size, vasospasms (caused by PPH) and/or thrombosis (associated with pregnancy or coagulation disorders) are predisposing factors; autoimmunity might be involved in the progressive worsening of pituitary functions."

The primary review hedges the autoimmune contribution as "might be involved", in contrast to the predisposing factors it states outright.

+ 3 more references

⚙

Pathophysiology

13

Pregnancy-Induced Lactotroph Hyperplasia and Anterior Pituitary Enlargement

Rising oestrogen through gestation drives hyperplasia of the prolactin-secreting lactotrophs of the anterior lobe, so the gland enlarges substantially by term. This is normal physiology preparing for lactation, but it is the reason the anterior pituitary enters the peripartum period with an increased metabolic demand.

lactotroph CL:0000439

lactotroph proliferation GO:0008283 ↑ INCREASED

anterior pituitary lobe UBERON:0002196

Downstream

Portal Perfusion and Fixed Sellar Volume Constrain Anterior Pituitary Blood Supply An enlarged gland inside an unyielding sella and fed by a portal system has less perfusion reserve than a non-pregnant one.

Show evidence (3 references)

PMID:19934270 SUPPORT Other

"The pituitary gland is enlarged as a result of lactotroph hyperplasia."

States the cellular basis of the pregnancy-associated enlargement modelled by this node.

PMID:31869188 SUPPORT Other

"The pituitary gland enlarges by about one-third to achieve these functional changes, with the major component of this growth being the estrogen-induced hyperplasia of the lactotroph cells."

Quantifies the enlargement and attributes it to oestrogen-induced lactotroph hyperplasia.

PMID:39863703 SUPPORT Other

"The pituitary gland is enlarged markedly during 3rd trimester of pregnancy and reaches to its highest volume in the early postpartum days leading to increased demand of blood supply"

Places the peak of the enlargement in the early postpartum days, which is exactly when the haemorrhagic insult occurs, and states the resulting increase in blood-supply demand.

Portal Perfusion and Fixed Sellar Volume Constrain Anterior Pituitary Blood Supply

The bulk of the anterior lobe is not supplied by direct arterial branches but by the long hypophyseal portal veins descending from the median eminence, whose tributaries arise far from the internal carotid artery; the posterior lobe and the marginal zone of the anterior lobe retain a more direct arterial supply. Because the whole gland is enclosed by the bony sella turcica, an enlarged gland in a small sella has little room to swell without further compromising this low-pressure inflow. Small sella volume is a documented predisposing factor.

sella turcica UBERON:0003689

Downstream

Ischaemic Infarction and Necrosis of the Anterior Pituitary The portal-dependent central anterior lobe is the territory that infarcts when perfusion pressure falls.

Relative Preservation of Posterior Pituitary Perfusion The posterior lobe, supplied more directly, remains enhanced when the portal-dependent anterior territory does not.

Show evidence (4 references)

PMID:24917653 SUPPORT Human Clinical

"Furthermore, small sella size may have an important contributing role in the etiopathogenesis of SS."

Case-control sella volumetry supporting fixed sellar volume as a predisposing anatomical factor.

PMID:24162077 SUPPORT Human Clinical

"The characteristic hook-shaped enhancement in Sheehan's syndrome well reflected the vulnerability to massive bleeding based on the complex pituitary vasculature, which has not been reported previously."

States that the pituitary's vascular architecture is what makes it vulnerable to massive bleeding.

PMID:37772209 SUPPORT Human Clinical

"Maternal gestational changes and adaptations include relative hyperplasia of the pituitary gland with minimal increase in blood supply to the hypothalamohypophyseal portal system due to increased blood flow being prioritized to reproductive organs."

States the mismatch this node models: the gland grows while its portal inflow does not keep pace.

+ 1 more reference

Postpartum Haemorrhage with Hypovolaemia and Portal Vasospasm

Massive obstetric haemorrhage produces systemic hypovolaemia and hypotension; vasospasm of the hypothalamic portal vessels, and in some patients pregnancy-associated or inherited thrombotic tendency, further reduce inflow to the anterior lobe.

Downstream

Ischaemic Infarction and Necrosis of the Anterior Pituitary Loss of perfusion pressure across the portal supply is the proximate cause of anterior-lobe infarction.

Show evidence (1 reference)

PMID:28004764 SUPPORT Other

"Small sella turcica size, vasospasms (caused by PPH) and/or thrombosis (associated with pregnancy or coagulation disorders) are predisposing factors; autoimmunity might be involved in the progressive worsening of pituitary functions."

Enumerates the haemodynamic and thrombotic contributors modelled by this node.

Ischaemic Infarction and Necrosis of the Anterior Pituitary

Sustained hypoperfusion of the portal-dependent anterior lobe produces ischaemic necrosis of the hormone-secreting cell populations. This is the defining lesion of the disease.

pituitary gland cell CL:2000004

cellular response to hypoxia GO:0071456 ↑ INCREASED

anterior pituitary lobe UBERON:0002196

Downstream

Loss of Anterior Pituitary Trophic Hormone Secretion Destruction of the secretory cell populations removes their hormone output.

Progressive Pituitary Atrophy and Empty Sella Formation The infarcted lobe involutes over months to years, leaving a partially or completely empty sella.

Show evidence (1 reference)

PMID:42175518 SUPPORT Human Clinical

"Sheehan syndrome is a rare but potentially fatal cause of hypopituitarism resulting from ischemic necrosis of the anterior pituitary following severe postpartum hemorrhage."

States the defining lesion modelled by this node.

Relative Preservation of Posterior Pituitary Perfusion

Because the neurohypophysis is supplied more directly than the portal-dependent anterior lobe, it is comparatively spared, and clinically overt central diabetes insipidus is not part of the usual presentation. The sparing is relative rather than absolute: formal water-deprivation testing detects partial neurohypophyseal impairment in a substantial minority of patients who have no symptoms of diabetes insipidus, and rare cases present with overt central diabetes insipidus.

posterior pituitary lobe UBERON:0002198

Show evidence (3 references)

PMID:18230820 SUPPORT Human Clinical

"None of them had clinical central diabetes insipidus."

In a cohort of 20 women with long-standing Sheehan syndrome, none had clinical diabetes insipidus, supporting relative posterior-lobe sparing.

PMID:17468192 REFUTE Human Clinical

"Our findings demonstrated that patients with Sheehan's syndrome have an impairment of neurohypophyseal function."

Formal testing contradicts a strong reading of posterior-lobe sparing: neurohypophyseal function is measurably impaired even when patients are asymptomatic. Recorded as REFUTE against the absolute claim so the qualification in this node's description is auditable.

PMID:17468192 SUPPORT Human Clinical

"According to dehydration test, 8 (29.6%) patients had partial diabetes insipidus (PDI group) and 19 (70.3%) had normal response (non-DI group)."

Quantifies the sparing: about 70% of tested patients had a normal water-deprivation response and the remainder had only partial impairment.

Loss of Anterior Pituitary Trophic Hormone Secretion

Necrosis removes trophic hormone output in a characteristic order that tracks the position of each cell type relative to the vasculature: prolactin and growth hormone secretion are lost first and most often, then the gonadotropins, and only with more extensive necrosis thyroid-stimulating hormone and adrenocorticotropic hormone. Deficiency may be partial at presentation and accumulate over subsequent years.

anterior pituitary lobe UBERON:0002196

Downstream

Prolactin Deficiency

Growth Hormone Deficiency

Gonadotropin Deficiency

Central Hypothyroidism from Thyroid-Stimulating Hormone Deficiency

Secondary Adrenal Insufficiency from Corticotropin Deficiency

Show evidence (2 references)

PMID:28004764 SUPPORT Other

"In accordance with the location of hormone-secreting cells relative to the vasculature, the secretion of growth hormone and prolactin is most commonly affected, followed by follicle-stimulating hormone and luteinizing hormone; severe necrosis of the pituitary gland also affects the secretion of..."

States both the ordering of axis loss and its vascular-anatomical basis.

PMID:36243797 SUPPORT Human Clinical

"Multiple (≥ 2) hormone deficiencies were present in 68.8% of patients, with hypothyroidism (91.4%), hypocortisolism (88.3%), and growth hormone (GH) deficiency (85.7%) being the most common."

Quantifies multi-axis involvement in a 60-patient Sheehan syndrome cohort.

Prolactin Deficiency

Loss of lactotrophs abolishes the prolactin surge required to initiate lactation. Because it presents immediately after the index delivery, it is the earliest available clinical clue.

lactotroph CL:0000439

prolactin secretion GO:0070459 ↓ DECREASED

Downstream

Failure of Postpartum Lactation

Show evidence (1 reference)

PMID:24917653 SUPPORT Human Clinical

"None of the patients whose basal prolactin was below 4.0 ng/ml had adequate prolactin responses to TRH test, while all patients whose basal prolactin was above 7.8 ng/ml had adequate responses."

Documents deficient lactotroph reserve on dynamic testing in this cohort.

Growth Hormone Deficiency

Somatotroph loss occurs in nearly all patients and is unusually severe in Sheehan syndrome compared with hypopituitarism of other causes. It is the principal driver of the adverse body-composition, lipid and hepatic phenotype that persists even on adequate glucocorticoid and thyroid replacement.

somatotroph CL:0002312

growth hormone secretion GO:0030252 ↓ DECREASED

Downstream

Hepatic Steatosis Growth hormone deficiency is a predictor of hepatic steatosis in Sheehan syndrome cohorts.

Increased Body Fat with Abdominal Predominance Growth hormone deficiency is named as the predominant contributor to the abdominal fat deposition that persists on other replacement.

Atherogenic Dyslipidemia The persistent adverse lipid profile is attributed to unreplaced growth hormone deficiency rather than to inadequate thyroid or glucocorticoid replacement.

Insulin Resistance Untreated growth hormone deficiency is described as driving insulin resistance in hypopituitary patients who are otherwise adequately replaced.

Metabolic Syndrome The composite metabolic syndrome is attributed jointly to growth hormone deficiency, glucocorticoid therapy and hypogonadism, so this edge carries only part of the causation.

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"Somatotroph and thyrotroph cell loss occurs in almost all patients, with preservation or recovery of gonadotroph, lactotroph, and corticotroph cell function in few"

States that somatotroph loss is near universal in Sheehan syndrome.

Gonadotropin Deficiency

Loss of luteinizing hormone and follicle-stimulating hormone secretion prevents resumption of menstrual cycles after the puerperium and produces hypogonadotropic hypogonadism with loss of secondary sexual hair.

gonadotroph CL:0000437

gonadotropin secretion GO:0032274 ↓ DECREASED

Downstream

Secondary Amenorrhoea

Loss of Axillary and Pubic Hair

Osteoporosis The long untreated hypogonadism created by the diagnostic delay is the principal driver of bone loss, with the other unreplaced axes and non-physiological replacement dosing contributing.

Show evidence (1 reference)

PMID:41116860 SUPPORT Human Clinical

"A comprehensive endocrine evaluation revealed secondary adrenal insufficiency, central hypothyroidism, and hypogonadotropic hypogonadism, as evidenced by low levels of ACTH, cortisol, TSH, free T4, FSH, LH, and prolactin."

Documents biochemically confirmed hypogonadotropic hypogonadism in Sheehan syndrome.

Central Hypothyroidism from Thyroid-Stimulating Hormone Deficiency

Thyrotroph loss removes the pituitary drive to the thyroid, so thyroid hormone synthesis falls without the compensatory rise in thyroid-stimulating hormone that characterises primary hypothyroidism. This node substitutes the disorder-specific lesion, central thyroid-stimulating hormone deficiency, for the module's generic impairment of thyroid hormone synthesis.

thyrotroph CL:0000476 thyroid follicular cell CL:0002258

thyroid-stimulating hormone secretion GO:0070460 ↓ DECREASED thyroid hormone generation GO:0006590 ↓ DECREASED

Downstream

Reduced Thyroid Hormone Action and Hypometabolism

Show evidence (1 reference)

PMID:42175518 SUPPORT Human Clinical

"Laboratory investigations demonstrated microcytic hypochromic anemia, leukocytosis with neutrophilia, hyponatremia, markedly low morning cortisol (0.6 µg/dL), low FT3 and FT4, and low-normal TSH, consistent with panhypopituitarism."

The combination of low free thyroid hormones with a low-normal rather than elevated TSH is the biochemical signature of the central lesion modelled here.

Reduced Thyroid Hormone Action and Hypometabolism

Diminished circulating thyroid hormone lowers thyroid hormone action at peripheral target tissues, producing the hypometabolic symptom set shared with hypothyroidism of any cause.

response to thyroid hormone GO:0097066 ↓ DECREASED regulation of metabolic process GO:0019222 ↓ DECREASED

Downstream

Cold Intolerance

Chronic Fatigue

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"The major clinical features of typical and complete SS include lactation failure, failure of resumption of menstrual cycles after the puerperium, loss of pubic and axillary hair, symptoms of hypothyroidism, and hypocortisolism"

Lists symptomatic hypothyroidism among the core clinical features of the disease, which is the peripheral consequence modelled here.

Secondary Adrenal Insufficiency from Corticotropin Deficiency

Corticotroph loss removes adrenocorticotropic hormone drive to the adrenal cortex. Because it usually requires more extensive necrosis, it appears later than prolactin and gonadotropin loss, but it is the deficiency that makes the disease lethal: an intercurrent illness in an unreplaced patient can precipitate adrenal crisis.

corticotroph CL:0002309

corticotropin secretion GO:0051458 ↓ DECREASED

Downstream

Adrenal Crisis

Hyponatraemia

Hypoglycaemia

Show evidence (1 reference)

PMID:24917653 SUPPORT Human Clinical

"It was found that 52.6% of patients had nonspecific complaints, 30.7% had complaints related to adrenal insufficiency, and 9.6% had complaints related to hypogonadism when diagnosed."

Nearly a third of this cohort presented with adrenal-insufficiency complaints, supporting corticotroph failure as a major clinical outcome.

Progressive Pituitary Atrophy and Empty Sella Formation

Over months to years the infarcted gland involutes, and cerebrospinal fluid fills the sella, producing the partial or complete empty sella seen on MRI in long-standing disease. This is a radiological consequence of the index infarct, not an independent lesion.

sella turcica UBERON:0003689

Show evidence (2 references)

PMID:41116860 SUPPORT Human Clinical

"Magnetic resonance imaging (MRI) confirmed partial empty sella, supporting the diagnosis of SS."

Documents the empty sella as the chronic-phase imaging finding used to support the diagnosis. The corresponding imaging_findings entry records the radiological observation itself.

PMID:39863703 SUPPORT Other

"In the end, a fibrous scar replaces the necrotic pituitary by time leading to empty sella appearence radiologically."

States the tissue process, fibrous replacement of necrotic gland, that produces the empty sella modelled by this node.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

21

Blood 1

Anaemia Anemia HP:0001903

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"Less common manifestations of SS include hematological abnormalities (like anemia and pancytopenia), cardiac abnormalities (like cardiomyopathy and ventricular arrhythmias), and neuropsychiatric abnormalities (like psychosis)"

Lists anaemia among the less common haematological manifestations.

Breast 1

Failure of Postpartum Lactation VERY_FREQUENT Agalactia HP:0031109

Show evidence (2 references)

PMID:28004764 SUPPORT Other

"Symptoms are caused by a decrease or absence of one or more of the pituitary hormones, and vary, among others, from failure to lactate and nonspecific symptoms (such as fatigue) to severe adrenal crisis."

Names failure to lactate as a presenting manifestation of the hormone deficiency.

PMID:36742387 SUPPORT Other

"The major clinical features of typical and complete SS include lactation failure, failure of resumption of menstrual cycles after the puerperium, loss of pubic and axillary hair, symptoms of hypothyroidism, and hypocortisolism"

Lists lactation failure first among the major clinical features, supporting the VERY_FREQUENT band.

Cardiovascular 1

Hypotension HP:0002615

Show evidence (1 reference)

PMID:41116860 SUPPORT Human Clinical

"Affected individuals may present with signs and symptoms including weight gain or loss, cold intolerance, hair loss, menstrual irregularities, and hypotension."

Lists hypotension among the presenting features of the syndrome.

Digestive 1

Hepatic Steatosis FREQUENT HP:0001397

Show evidence (1 reference)

PMID:36243797 SUPPORT Human Clinical

"At a mean follow-up of 9.8 ± 6.8 years, NAFLD was present in 63% of patients, with 51% having severe steatosis, which was predicted by the presence of GH deficiency and higher body mass index."

Reports NAFLD in 63% of patients at long-term follow-up, supporting the FREQUENT band.

Endocrine 6

Hypogonadotropic Hypogonadism HP:0000044

Show evidence (1 reference)

PMID:41116860 SUPPORT Human Clinical

"A comprehensive endocrine evaluation revealed secondary adrenal insufficiency, central hypothyroidism, and hypogonadotropic hypogonadism, as evidenced by low levels of ACTH, cortisol, TSH, free T4, FSH, LH, and prolactin."

Reports the biochemically confirmed hypogonadotropic hypogonadism.

Central Hypothyroidism VERY_FREQUENT Pituitary hypothyroidism HP:0008245

Show evidence (1 reference)

PMID:36243797 SUPPORT Human Clinical

"Multiple (≥ 2) hormone deficiencies were present in 68.8% of patients, with hypothyroidism (91.4%), hypocortisolism (88.3%), and growth hormone (GH) deficiency (85.7%) being the most common."

Reports hypothyroidism in 91.4% of a 60-patient Sheehan syndrome cohort, supporting the VERY_FREQUENT band.

Secondary Adrenal Insufficiency VERY_FREQUENT Adrenocorticotropin deficient adrenal insufficiency HP:0011735

Show evidence (1 reference)

PMID:36243797 SUPPORT Human Clinical

"Multiple (≥ 2) hormone deficiencies were present in 68.8% of patients, with hypothyroidism (91.4%), hypocortisolism (88.3%), and growth hormone (GH) deficiency (85.7%) being the most common."

Reports hypocortisolism in 88.3% of this cohort.

Adrenal Crisis Adrenal insufficiency HP:0000846

Temporal: ACUTE

Sequelae: Hyponatraemia

Show evidence (2 references)

PMID:42175518 SUPPORT Human Clinical

"Because symptoms often develop gradually and nonspecifically, diagnosis is frequently delayed until acute illness precipitates adrenal crisis or severe hypoglycemia."

States that acute illness precipitating adrenal crisis is a common route to diagnosis.

PMID:41116860 SUPPORT Human Clinical

"She developed an adrenal crisis during pregnancy, which was managed through hydrocortisone dose modification."

Documents an adrenal crisis occurring in a diagnosed and replaced patient under physiological stress.

Growth Hormone Deficiency VERY_FREQUENT Secondary growth hormone deficiency HP:0008240

Show evidence (1 reference)

PMID:36243797 SUPPORT Human Clinical

"Multiple (≥ 2) hormone deficiencies were present in 68.8% of patients, with hypothyroidism (91.4%), hypocortisolism (88.3%), and growth hormone (GH) deficiency (85.7%) being the most common."

Reports growth hormone deficiency in 85.7% of this cohort.

Diabetes Mellitus OCCASIONAL HP:0000819

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"Around one fourth of patients with SS had diabetes mellitus"

Gives the approximately one-in-four figure that the OCCASIONAL band is taken from.

Genitourinary 1

Secondary Amenorrhoea VERY_FREQUENT Secondary amenorrhea HP:0000869

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"The major clinical features of typical and complete SS include lactation failure, failure of resumption of menstrual cycles after the puerperium, loss of pubic and axillary hair, symptoms of hypothyroidism, and hypocortisolism"

Names failure to resume menses among the major clinical features.

Integument 1

Loss of Axillary and Pubic Hair Absent axillary hair HP:0002221

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"The major clinical features of typical and complete SS include lactation failure, failure of resumption of menstrual cycles after the puerperium, loss of pubic and axillary hair, symptoms of hypothyroidism, and hypocortisolism"

Names loss of pubic and axillary hair among the major clinical features.

Metabolism 5

Hyponatraemia Hyponatremia HP:0002902

Show evidence (1 reference)

PMID:42175518 SUPPORT Human Clinical

"Laboratory investigations demonstrated microcytic hypochromic anemia, leukocytosis with neutrophilia, hyponatremia, markedly low morning cortisol (0.6 µg/dL), low FT3 and FT4, and low-normal TSH, consistent with panhypopituitarism."

Reports hyponatraemia in a patient presenting with Sheehan syndrome.

Hypoglycaemia Hypoglycemia HP:0001943

Show evidence (1 reference)

PMID:42175518 SUPPORT Human Clinical

"A 48-year-old woman presented with central chest pain, productive cough, dyspnea, intermittent fever, severe anemia, and recurrent hypoglycemia."

Reports recurrent hypoglycaemia as a presenting feature.

Cold Intolerance HP:6000855

Show evidence (1 reference)

PMID:41116860 SUPPORT Human Clinical

"Affected individuals may present with signs and symptoms including weight gain or loss, cold intolerance, hair loss, menstrual irregularities, and hypotension."

Lists cold intolerance among the presenting features of the syndrome.

Atherogenic Dyslipidemia Abnormal circulating lipid concentration HP:0003119

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"Inspite of thyroxine and GC replacement, patients with SS have adverse lipid parameters like increased serum total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and triglycerides (TG) and low high density lipoprotein cholesterol (HDL-C)."

Names each of the four lipid changes and states that they persist on thyroid and glucocorticoid replacement.

Insulin Resistance HP:0000855

Sequelae: Diabetes Mellitus

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"Homeostasis model assessment-insulin resistance (HOMA-IR), an index of IR was high in large group of women with SS compared to healthy controls"

Reports HOMA-IR as high in women with Sheehan syndrome compared with healthy controls, which is the measurement behind this phenotype.

Musculoskeletal 1

Osteoporosis FREQUENT HP:0000939

Show evidence (2 references)

PMID:39863703 SUPPORT Other

"In another study including 60 patients with SS, osteopenia was found to be present 41.7 and osteoporosis in 35.0% of the patients and bone mineral density (BMD) was found to be significantly lower compared to the control group."

Reports osteoporosis in 35.0% of a 60-patient Sheehan syndrome cohort with bone mineral density significantly below matched controls, which is the basis for the FREQUENT band.

PMID:39863703 SUPPORT Other

"Sheehan syndrome increases the risk of osteoporosis and osteopenia"

States the association between the disease and osteoporosis directly.

Constitutional 1

Chronic Fatigue VERY_FREQUENT HP:0012432

Temporal: CHRONIC

Show evidence (2 references)

PMID:36742387 SUPPORT Other

"SS presents with long-standing non-specific symptoms of fatigue and generalized body aches."

States that long-standing non-specific fatigue is the typical presentation.

PMID:24917653 SUPPORT Human Clinical

"It was found that 52.6% of patients had nonspecific complaints, 30.7% had complaints related to adrenal insufficiency, and 9.6% had complaints related to hypogonadism when diagnosed."

More than half of this cohort presented with non-specific complaints, supporting the VERY_FREQUENT band.

Growth 1

Increased Body Fat with Abdominal Predominance Abdominal obesity HP:0012743

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"patients with SS in comparison to age and gender matched population have increased body mass index (BMI) and total body fat with predominant abdominal fat deposition"

States the increase in total body fat and its abdominal predominance relative to matched controls.

Other 1

Metabolic Syndrome FREQUENT abdominal obesity-metabolic syndrome MONDO:0000816

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"The prevalence of MS in SS is around 50% with major constituents being increased WC, decreased HDL-C and increased TG."

States the prevalence of metabolic syndrome in Sheehan syndrome as around 50%, which is the basis for the FREQUENT band, and names its constituents.

💊

Medical Actions

5

Lifelong Pituitary Hormone Replacement

Category: Therapeutic Action: Hormone Replacement Therapy NCIT:C15599

Platform: Other

There is no way to restore the infarcted gland, so management is lifelong replacement of the deficient target hormones, adjusted for stress and reviewed as further axes fail.

Mechanism Target:

BYPASSES Loss of Anterior Pituitary Trophic Hormone Secretion — Replacement supplies the target-gland hormones directly, bypassing the absent pituitary trophic drive.

Show evidence (2 references)

PMID:28004764 SUPPORT Other

"Hormone replacement therapy is the only available management option so far."

States that replacement is the only available management, which is the claim this treatment entry makes.

PMID:41116860 SUPPORT Human Clinical

"She was started on lifelong hormone replacement therapy (HRT) consisting of hydrocortisone, levothyroxine, and estrogen."

Documents the composition of lifelong replacement in a treated patient.

Glucocorticoid Replacement

Category: Therapeutic Action: Pharmacotherapy NCIT:C15986

Agent: hydrocortisone CHEBI:17650

Platform: Small molecule

Hydrocortisone replacement for secondary adrenal insufficiency, with stress dosing during illness, surgery and pregnancy. Critically, glucocorticoid must be started BEFORE thyroid hormone: correcting hypothyroidism first raises metabolic clearance of the little cortisol that remains and can precipitate an adrenal crisis.

Mechanism Target:

BYPASSES Secondary Adrenal Insufficiency from Corticotropin Deficiency — Exogenous glucocorticoid replaces the cortisol the adrenal cortex no longer makes without corticotropin drive.

Target Phenotypes: adrenocorticotropin deficient adrenal insufficiency HP:0011735

Show evidence (4 references)

PMID:42175518 SUPPORT Human Clinical

"The patient was started on oral glucocorticoid replacement with prednisolone 10 mg daily to address adrenal insufficiency, with plans for lifelong maintenance and stress-dose adjustments during periods of illness or surgery."

Documents lifelong glucocorticoid replacement with stress dosing in a patient with Sheehan syndrome.

PMID:42175518 SUPPORT Human Clinical

"glucocorticoid replacement should always precede thyroid hormone initiation in suspected or confirmed adrenal insufficiency to avoid precipitating adrenal crisis"

States the sequencing rule that makes this treatment ordering-critical, and the harm it prevents.

PMID:37772209 SUPPORT Human Clinical

"Without appropriate steroid supplementation exogenously, patients can rapidly decline with adverse hypotension, altered mental status, and loss of vascular tone."

Describes the decompensation that follows interruption of glucocorticoid replacement, in a case where missed doses precipitated adrenal crisis.

+ 1 more reference

Levothyroxine Replacement

Category: Therapeutic Action: Pharmacotherapy NCIT:C15986

Agent: levothyroxine CHEBI:6446

Platform: Small molecule

Levothyroxine for central hypothyroidism, titrated on free thyroxine rather than thyroid-stimulating hormone because the pituitary feedback arm is the lesion. It must not be started before glucocorticoid replacement in a patient with suspected or confirmed adrenal insufficiency.

Mechanism Target:

BYPASSES Central Hypothyroidism from Thyroid-Stimulating Hormone Deficiency — Exogenous thyroxine replaces the hormone the thyroid no longer makes without thyroid-stimulating hormone drive.

Target Phenotypes: pituitary hypothyroidism HP:0008245

Show evidence (1 reference)

PMID:42175518 SUPPORT Human Clinical

"The patient was treated with glucocorticoid replacement therapy, followed by levothyroxine supplementation."

Documents levothyroxine replacement given after, not before, glucocorticoid.

Sex Steroid Replacement

Category: Therapeutic Action: Estrogen Replacement Therapy NCIT:C15231

Platform: Small molecule

Oestrogen with progestogen for hypogonadotropic hypogonadism until the expected age of menopause, to relieve symptoms and limit bone loss. Fertility requires gonadotropin therapy rather than sex steroids.

Mechanism Target:

BYPASSES Gonadotropin Deficiency — Exogenous sex steroid replaces the ovarian output that absent gonadotropin drive no longer supports.

Target Phenotypes: hypogonadotropic hypogonadism HP:0000044

Show evidence (1 reference)

PMID:41116860 SUPPORT Human Clinical

"Pregnancy was later achieved through ovulation induction using human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG)."

Shows that sex steroid replacement does not restore fertility, which requires gonadotropin therapy instead.

Growth Hormone Replacement

Category: Therapeutic Action: Pharmacotherapy NCIT:C15986

Agent: somatropin NCIT:C837

Platform: Protein replacement

Recombinant growth hormone added to standard replacement in selected patients, which improves the cardiometabolic profile that persists on glucocorticoid, thyroid and sex steroid replacement alone.

Mechanism Target:

BYPASSES Growth Hormone Deficiency — Recombinant growth hormone replaces the absent somatotroph output.

Target Phenotypes: secondary growth hormone deficiency HP:0008240 atherogenic dyslipidemia HP:0003119 abdominal obesity HP:0012743

Show evidence (2 references)

PMID:36742387 SUPPORT Other

"Replacement with GH in addition to standard hormone replacement improves their cardiometabolic profile."

States the benefit of adding growth hormone to standard replacement in this disease.

PMID:36742387 SUPPORT Other

"GH treatment had a favourable effect on CIMT, lipids and visceral fat."

Names the lipid and visceral-fat improvements that connect this treatment to the dyslipidemia and abdominal-obesity phenotypes it targets.

🔬

Diagnosis

2

Dynamic Prolactin Testing

Basal prolactin plus a thyrotropin-releasing hormone stimulation test discriminates lactotroph reserve, and was reported to have high sensitivity and specificity for prolactin deficiency in Sheehan syndrome.

Show evidence (1 reference)

PMID:24917653 SUPPORT Human Clinical

"In addition, the TRH stimulation test was found to have a high sensitivity and specificity to recognize PRL deficiency."

States the diagnostic performance of the test in this cohort.

Clinical Diagnosis on Obstetric History and Hormone Testing

Diagnosis rests on the combination of a history of severe postpartum haemorrhage with basal hormone levels and, where needed, stimulation tests.

Show evidence (1 reference)

PMID:28004764 SUPPORT Other

"Diagnosis is based on clinical manifestations combined with a history of severe PPH; hormone levels and/or stimulation tests can confirm clinical suspicion."

States the diagnostic approach.

🩻

Imaging Findings

2

Empty Sella on Magnetic Resonance Imaging

Partial or complete empty sella, the chronic-phase radiological correlate of anterior pituitary infarction and involution.

Mri Diagnostic

empty sella turcica HP:6000483 sella turcica UBERON:0003689

Show evidence (1 reference)

PMID:41116860 SUPPORT Human Clinical

"Magnetic resonance imaging (MRI) confirmed partial empty sella, supporting the diagnosis of SS."

Reports the empty sella as a diagnostic imaging finding in Sheehan syndrome.

Acute Anterior Lobe Swelling and Non-Enhancement

In the acute phase, contrast-enhanced MRI shows a swollen anterior lobe with a non-enhancing central territory while the stalk, the marginal zone and the posterior lobe still enhance.

Mri

anterior pituitary lobe UBERON:0002196

Show evidence (1 reference)

PMID:24162077 SUPPORT Human Clinical

"In contrast, the central portion and the superior margin, just in front of the stalk insertion of the anterior lobe, were not enhanced."

Describes the non-enhancing infarcted territory that defines the acute imaging appearance.

📈

Progression

5

Peripartum insult

Severe postpartum haemorrhage with hypovolaemia; the anterior lobe may be swollen on contrast MRI in the first days to weeks after delivery.

Show evidence (1 reference)

PMID:24162077 SUPPORT Human Clinical

"MR image of the pituitary gland on postpartum day 10 revealed swelling of the anterior lobe."

Documents the acute-phase appearance of the infarcted anterior lobe within days of the haemorrhage.

Acute Sheehan syndrome (rare)

A minority of patients decompensate within days to weeks of delivery rather than presenting years later. In a review of 21 reported acute cases the median time from delivery to presentation was under three weeks, and adrenal insufficiency was the commonest presenting picture.

Show evidence (2 references)

PMID:28615049 SUPPORT Human Clinical

"An electronic search of the literature yielded 21 cases of acute Sheehan's syndrome. Presenting signs varied, including adrenal insufficiency (12 cases), diabetes insipidus (4 cases), hypothyroidism (2 cases), and panhypopituitarism (3 cases), with a median time of presentation after delivery..."

Gives the presenting syndromes and their median timing in the acute form.

PMID:28004764 SUPPORT Other

"Symptoms usually become evident years after delivery, but can, in rare cases, develop acutely."

Confirms that acute presentation is the rare exception to the usual latent course.

Latent hypopituitarism

Failure to lactate and failure to resume menses are usually the earliest manifestations, followed by years of non-specific fatigue that are commonly misattributed to postpartum depression or chronic fatigue.

Show evidence (1 reference)

PMID:41116860 SUPPORT Human Clinical

"Initially, she experienced failure to lactate, followed by amenorrhea, frontal balding, weight loss, hypotension, chronic fatigue, mood swings, and polyuria."

Illustrates the ordered emergence of deficiency symptoms in the latent phase.

Diagnosis, often years to decades later

Diagnosis is typically made only after a long delay, and in a substantial minority is triggered by an acute adrenal decompensation.

Show evidence (3 references)

PMID:24917653 SUPPORT Human Clinical

"The mean period of diagnostic delay was 19.7 years in patients with SS."

Quantifies the diagnostic delay in the largest reported single-centre series.

PMID:26323346 SUPPORT Other

"Sheehan's syndrome (SS) is a parturition-related pituitary disease resulting from severe postpartum hemorrhage and can present with varying degrees of pituitary insufficiency. ... Additionally, the diagnosis of SS has often been overlooked and thus delayed for long years due to its nonspecific..."

Identifies Sheehan syndrome and its frequently delayed diagnosis. This excerpt does not quantify presentation with acute adrenal decompensation.

PMID:39863703 SUPPORT Other

"most patients present with nonspecific symptoms leading to a variable delay in diagnosis about 7–19 years"

Gives the range of reported diagnostic delays across published series, complementing the single-cohort mean above.

Progressive multi-axis failure

The number of deficient axes increases with time from the index haemorrhage, so partial hypopituitarism at presentation does not exclude later panhypopituitarism.

Show evidence (1 reference)

PMID:24917653 SUPPORT Human Clinical

"The number of deficient hormones was found to be increased over the years."

Directly supports progressive rather than static endocrine loss.

📊

Prevalence

2

Iceland (population-based study)

Point Prevalence 5.1 per 100,000 1–9 per 100,000

Population-based Icelandic figure quoted in a Sheehan syndrome review as 5.1 diagnosed individuals per 100,000 population.

Show evidence (1 reference)

PMID:36742387 SUPPORT Other

"In a population based study from Iceland, SS was diagnosed in 5.1 individuals per 100,000 population"

Gives the population-based point-prevalence figure for a well-resourced-obstetric-care setting.

Parous women aged 20 years and over, Kashmir valley, India

Point Prevalence 3000.0 per 100,000 >1 in 1,000

Community screening of parous women in the Kashmir valley found around 3% of women over 20 years of age affected, roughly 600-fold the Icelandic figure. The contrast is the burden signal for this disease.

Show evidence (2 references)

PMID:16084902 SUPPORT Human Clinical

"At these rates, the projected number of women with Sheehan's syndrome among a total population of parous females aged > or =20 years (12,32,827, as per census data) would be 38,691 in the Kashmir valley of the Indian subcontinent."

Community-based screening study projecting the affected population in a setting with historically limited obstetric care.

PMID:36742387 SUPPORT Other

"whereas the prevalence of SS among 11,700 women >20 years of age was around 3% in northern India"

States the northern-India prevalence as approximately 3%, the value normalised into rate_per_100000 here.

⚖️

Clinical Burden

High

Untreated Sheehan syndrome carries a risk of fatal adrenal crisis, and even treated patients accumulate metabolic and cardiovascular morbidity. The burden is concentrated where obstetric haemorrhage is poorly managed, and is compounded by a diagnostic delay measured in years to decades.

Show evidence (3 references)

PMID:36742387 SUPPORT Other

"The lower prevalence of SS in developed countries is a result of better obstetric care facilities in these countries and possibly disease unawareness and missed diagnosis."

Attributes the geographic skew in disease burden to the quality of obstetric care rather than to any biological difference in susceptibility.

PMID:28004764 SUPPORT Other

"Sheehan syndrome is an important cause of hypopituitarism in developing countries, but has become rare in developed countries."

Confirms that the disease burden falls disproportionately on settings with limited obstetric care.

PMID:39863703 SUPPORT Other

"The diagnostic delay makes the patients to expose hypopituitarism without essential replacement therapies leading to increased morbidity and mortality of the patients."

Connects the diagnostic delay directly to excess morbidity and mortality, which is why the burden is rated HIGH despite an effective treatment existing.

🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Sheehan Syndrome:

Lymphocytic hypophysitis

Overlapping Features Autoimmune hypophysitis also causes peripartum hypopituitarism, but it is not preceded by obstetric haemorrhage and typically shows a symmetrically enlarged, homogeneously enhancing gland with stalk thickening rather than an infarct progressing to an empty sella.

Distinguishing Features

Absence of severe postpartum haemorrhage in the index pregnancy
Pituitary enlargement rather than infarction and later atrophy

Show evidence (1 reference)

PMID:9880116 SUPPORT Other

"Hypopituitarism arising postpartum may be caused by either lymphocytic hypophysitis or Sheehan's syndrome, and the latter may present as an acute or chronic syndrome."

Names lymphocytic hypophysitis as the alternative cause of postpartum hypopituitarism that must be distinguished.

Postpartum depression

Overlapping Features The non-specific fatigue, low mood and weight change of untreated hypopituitarism are commonly attributed to postpartum depression, which is a principal reason for the long diagnostic delay.

Distinguishing Features

Failure of lactation and failure to resume menses
Biochemical multi-axis pituitary hormone deficiency

Show evidence (1 reference)

PMID:41116860 SUPPORT Human Clinical

"Diagnosis is often delayed due to its nonspecific presentation and overlap with conditions like postpartum depression and chronic fatigue syndrome."

Names postpartum depression as the condition Sheehan syndrome is commonly mistaken for.

{ }

Source YAML

click to show

name: Sheehan Syndrome
creation_date: "2026-09-05T00:00:00Z"
category: Acquired
disease_term:
  preferred_term: Sheehan syndrome
  term:
    id: MONDO:0019618
    label: Sheehan syndrome
parents:
- syndromic disease
synonyms:
- Sheehan's syndrome
- postpartum hypopituitarism
- postpartum pituitary necrosis
- postpartum panhypopituitarism
description: >-
  Sheehan syndrome is acquired hypopituitarism caused by ischaemic infarction and
  necrosis of the anterior pituitary in the setting of severe postpartum
  haemorrhage. During pregnancy the anterior lobe enlarges through
  oestrogen-driven lactotroph hyperplasia while remaining confined within the
  bony sella turcica and dependent on the low-pressure hypophyseal portal
  circulation, so peripartum hypovolaemia and portal vasospasm can infarct it.
  Trophic hormone secretion is then lost, classically beginning with prolactin
  and growth hormone and extending to the gonadotropins, thyroid-stimulating
  hormone and adrenocorticotropic hormone, while the separately supplied
  posterior lobe is comparatively preserved. Presentation is dominated by
  failure of postpartum lactation, amenorrhoea and non-specific fatigue, so
  diagnosis is typically delayed by years to decades and may first be made when
  an intercurrent illness precipitates adrenal crisis. It is a leading cause of
  hypopituitarism where obstetric care is limited and is uncommon where
  postpartum haemorrhage is well managed.
notes: >-
  This entry is deliberately distinct from
  Combined_Pituitary_Hormone_Deficiencies_Genetic_Form, which models congenital
  hypopituitarism arising from germline defects in pituitary organogenesis and
  lineage specification. The two converge on a shared endocrine deficiency state
  but have unrelated proximate mechanisms: Sheehan syndrome is a peripartum
  vascular lesion of a structurally normal, physiologically enlarged gland, and
  its pathophysiology chain is therefore modelled from pregnancy-induced
  hyperplasia through infarction, not from developmental transcription-factor
  failure.

  No animal, organoid or computational model reproducing the full sequence -
  pregnancy-associated pituitary enlargement, obstetric haemorrhagic shock,
  selective postpartum infarction, empty sella and multi-axis failure - was
  found during curation, so the model sections are deliberately empty rather
  than populated with partial surrogates such as hypophysectomy or generic
  haemorrhagic-shock preparations. There is no causal gene, so no genetic model
  is possible in principle.
references:
- reference: PMID:28004764
  title: Sheehan syndrome.
- reference: PMID:26323346
  title: "Sheehan's syndrome: new insights into an old disease."
- reference: PMID:39863703
  title: "Sheehan syndrome: a current approach to a dormant disease."
- reference: PMID:9880116
  title: Pituitary diseases in pregnancy.
- reference: PMID:16084902
  title: "Epidemiologic aspects of postpartum pituitary hypofunction (Sheehan's syndrome)."
- reference: PMID:17468192
  title: "Posterior pituitary function in Sheehan's syndrome."
- reference: PMID:18230820
  title: "Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome."
- reference: PMID:19934270
  title: Pregnancy and pituitary disorders.
- reference: PMID:24162077
  title: "A novel hook-shaped enhancement on contrast-enhanced sagittal magnetic resonance image in acute Sheehan's syndrome: a case report."
- reference: PMID:24917653
  title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
- reference: PMID:28615049
  title: "A case of acute Sheehan's syndrome and literature review: a rare but life-threatening complication of postpartum hemorrhage."
- reference: PMID:31869188
  title: "Physiology, Pituitary Issues During Pregnancy."
- reference: PMID:36243797
  title: "Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome."
- reference: PMID:36742387
  title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
- reference: PMID:37772209
  title: Adrenal Crisis in a Delayed Diagnosis of Sheehan Syndrome.
- reference: PMID:41116860
  title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
- reference: PMID:42175518
  title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
prevalence:
- population: Iceland (population-based study)
  measure_type: POINT_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 5.1
  rate_denominator: POPULATION
  notes: >-
    Population-based Icelandic figure quoted in a Sheehan syndrome review as
    5.1 diagnosed individuals per 100,000 population.
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "In a population based study from Iceland, SS was diagnosed in 5.1 individuals per 100,000 population"
    explanation: >-
      Gives the population-based point-prevalence figure for a
      well-resourced-obstetric-care setting.
- population: Parous women aged 20 years and over, Kashmir valley, India
  measure_type: POINT_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 3000.0
  rate_denominator: POPULATION
  notes: >-
    Community screening of parous women in the Kashmir valley found around 3%
    of women over 20 years of age affected, roughly 600-fold the Icelandic
    figure. The contrast is the burden signal for this disease.
  evidence:
  - reference: PMID:16084902
    reference_title: "Epidemiologic aspects of postpartum pituitary hypofunction (Sheehan's syndrome)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At these rates, the projected number of women with Sheehan's syndrome among a total population of parous females aged > or =20 years (12,32,827, as per census data) would be 38,691 in the Kashmir valley of the Indian subcontinent."
    explanation: >-
      Community-based screening study projecting the affected population in a
      setting with historically limited obstetric care.
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "whereas the prevalence of SS among 11,700 women >20 years of age was around 3% in northern India"
    explanation: >-
      States the northern-India prevalence as approximately 3%, the value
      normalised into rate_per_100000 here.
clinical_burden:
  burden_level: HIGH
  rationale: >-
    Untreated Sheehan syndrome carries a risk of fatal adrenal crisis, and even
    treated patients accumulate metabolic and cardiovascular morbidity. The
    burden is concentrated where obstetric haemorrhage is poorly managed, and is
    compounded by a diagnostic delay measured in years to decades.
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The lower prevalence of SS in developed countries is a result of better obstetric care facilities in these countries and possibly disease unawareness and missed diagnosis."
    explanation: >-
      Attributes the geographic skew in disease burden to the quality of
      obstetric care rather than to any biological difference in susceptibility.
  - reference: PMID:28004764
    reference_title: Sheehan syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Sheehan syndrome is an important cause of hypopituitarism in developing countries, but has become rare in developed countries."
    explanation: >-
      Confirms that the disease burden falls disproportionately on settings with
      limited obstetric care.
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The diagnostic delay makes the patients to expose hypopituitarism without essential replacement therapies leading to increased morbidity and mortality of the patients."
    explanation: >-
      Connects the diagnostic delay directly to excess morbidity and mortality,
      which is why the burden is rated HIGH despite an effective treatment
      existing.
progression:
- phase: Peripartum insult
  notes: >-
    Severe postpartum haemorrhage with hypovolaemia; the anterior lobe may be
    swollen on contrast MRI in the first days to weeks after delivery.
  evidence:
  - reference: PMID:24162077
    reference_title: "A novel hook-shaped enhancement on contrast-enhanced sagittal magnetic resonance image in acute Sheehan's syndrome: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "MR image of the pituitary gland on postpartum day 10 revealed swelling of the anterior lobe."
    explanation: >-
      Documents the acute-phase appearance of the infarcted anterior lobe within
      days of the haemorrhage.
- phase: Acute Sheehan syndrome (rare)
  notes: >-
    A minority of patients decompensate within days to weeks of delivery rather
    than presenting years later. In a review of 21 reported acute cases the
    median time from delivery to presentation was under three weeks, and adrenal
    insufficiency was the commonest presenting picture.
  evidence:
  - reference: PMID:28615049
    reference_title: "A case of acute Sheehan's syndrome and literature review: a rare but life-threatening complication of postpartum hemorrhage."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "An electronic search of the literature yielded 21 cases of acute Sheehan's syndrome. Presenting signs varied, including adrenal insufficiency (12 cases), diabetes insipidus (4 cases), hypothyroidism (2 cases), and panhypopituitarism (3 cases), with a median time of presentation after delivery for each of those conditions being 7.9, 4, 18, and 9 days, respectively."
    explanation: >-
      Gives the presenting syndromes and their median timing in the acute form.
  - reference: PMID:28004764
    reference_title: Sheehan syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Symptoms usually become evident years after delivery, but can, in rare cases, develop acutely."
    explanation: >-
      Confirms that acute presentation is the rare exception to the usual latent
      course.
- phase: Latent hypopituitarism
  notes: >-
    Failure to lactate and failure to resume menses are usually the earliest
    manifestations, followed by years of non-specific fatigue that are commonly
    misattributed to postpartum depression or chronic fatigue.
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Initially, she experienced failure to lactate, followed by amenorrhea, frontal balding, weight loss, hypotension, chronic fatigue, mood swings, and polyuria."
    explanation: >-
      Illustrates the ordered emergence of deficiency symptoms in the latent
      phase.
- phase: Diagnosis, often years to decades later
  notes: >-
    Diagnosis is typically made only after a long delay, and in a substantial
    minority is triggered by an acute adrenal decompensation.
  evidence:
  - reference: PMID:24917653
    reference_title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mean period of diagnostic delay was 19.7 years in patients with SS."
    explanation: >-
      Quantifies the diagnostic delay in the largest reported single-centre
      series.
  - reference: PMID:26323346
    reference_title: "Sheehan's syndrome: new insights into an old disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Sheehan's syndrome (SS) is a parturition-related pituitary disease resulting from severe
      postpartum hemorrhage and can present with varying degrees of pituitary insufficiency. ...
      Additionally, the diagnosis of SS has often been overlooked and thus delayed for long years
      due to its nonspecific signs and symptoms.
    explanation: >-
      Identifies Sheehan syndrome and its frequently delayed diagnosis. This excerpt does not
      quantify presentation with acute adrenal decompensation.
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "most patients present with nonspecific symptoms leading to a variable delay in diagnosis about 7–19 years"
    explanation: >-
      Gives the range of reported diagnostic delays across published series,
      complementing the single-cohort mean above.
- phase: Progressive multi-axis failure
  notes: >-
    The number of deficient axes increases with time from the index haemorrhage,
    so partial hypopituitarism at presentation does not exclude later
    panhypopituitarism.
  evidence:
  - reference: PMID:24917653
    reference_title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The number of deficient hormones was found to be increased over the years."
    explanation: >-
      Directly supports progressive rather than static endocrine loss.
pathophysiology:
- name: Pregnancy-Induced Lactotroph Hyperplasia and Anterior Pituitary Enlargement
  role: trigger
  biological_scale: CELLULAR
  description: >-
    Rising oestrogen through gestation drives hyperplasia of the
    prolactin-secreting lactotrophs of the anterior lobe, so the gland enlarges
    substantially by term. This is normal physiology preparing for lactation,
    but it is the reason the anterior pituitary enters the peripartum period
    with an increased metabolic demand.
  locations:
  - preferred_term: anterior pituitary lobe
    term:
      id: UBERON:0002196
      label: adenohypophysis
  cell_types:
  - preferred_term: lactotroph
    term:
      id: CL:0000439
      label: prolactin secreting cell
  biological_processes:
  - preferred_term: lactotroph proliferation
    term:
      id: GO:0008283
      label: cell population proliferation
    modifier: INCREASED
  downstream:
  - target: Portal Perfusion and Fixed Sellar Volume Constrain Anterior Pituitary Blood Supply
    causal_link_type: DIRECT
    description: >-
      An enlarged gland inside an unyielding sella and fed by a portal system
      has less perfusion reserve than a non-pregnant one.
    evidence:
    - reference: PMID:28004764
      reference_title: Sheehan syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "The initial insult is caused by massive postpartum haemorrhage (PPH), leading to impaired blood supply to the pituitary gland, which has become enlarged during pregnancy."
      explanation: >-
        Links the pregnancy-associated enlargement directly to the impaired
        blood supply that follows haemorrhage.
  evidence:
  - reference: PMID:19934270
    reference_title: Pregnancy and pituitary disorders.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The pituitary gland is enlarged as a result of lactotroph hyperplasia."
    explanation: >-
      States the cellular basis of the pregnancy-associated enlargement modelled
      by this node.
  - reference: PMID:31869188
    reference_title: "Physiology, Pituitary Issues During Pregnancy."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The pituitary gland enlarges by about one-third to achieve these functional changes, with the major component of this growth being the estrogen-induced hyperplasia of the lactotroph cells."
    explanation: >-
      Quantifies the enlargement and attributes it to oestrogen-induced
      lactotroph hyperplasia.
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The pituitary gland is enlarged markedly during 3rd trimester of pregnancy and reaches to its highest volume in the early postpartum days leading to increased demand of blood supply"
    explanation: >-
      Places the peak of the enlargement in the early postpartum days, which is
      exactly when the haemorrhagic insult occurs, and states the resulting
      increase in blood-supply demand.
- name: Portal Perfusion and Fixed Sellar Volume Constrain Anterior Pituitary Blood Supply
  role: predisposing factor
  biological_scale: TISSUE
  description: >-
    The bulk of the anterior lobe is not supplied by direct arterial branches but
    by the long hypophyseal portal veins descending from the median eminence,
    whose tributaries arise far from the internal carotid artery; the posterior
    lobe and the marginal zone of the anterior lobe retain a more direct arterial
    supply. Because the whole gland is enclosed by the bony sella turcica, an
    enlarged gland in a small sella has little room to swell without further
    compromising this low-pressure inflow. Small sella volume is a documented
    predisposing factor.
  locations:
  - preferred_term: sella turcica
    term:
      id: UBERON:0003689
      label: sella turcica
  downstream:
  - target: Ischaemic Infarction and Necrosis of the Anterior Pituitary
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      The portal-dependent central anterior lobe is the territory that infarcts
      when perfusion pressure falls.
    evidence:
    - reference: PMID:24162077
      reference_title: "A novel hook-shaped enhancement on contrast-enhanced sagittal magnetic resonance image in acute Sheehan's syndrome: a case report."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Anatomically, blood supply to these unenhanced portions of the anterior lobe was via the hypophyseal long portal vein and trabecular artery, which are tributaries of the superior hypophyseal artery that originate far from the internal carotid artery."
      explanation: >-
        Maps the non-perfused territory in acute Sheehan syndrome onto the
        portal-dependent vascular supply, supporting this edge specifically.
  - target: Relative Preservation of Posterior Pituitary Perfusion
    causal_link_type: DIRECT
    description: >-
      The posterior lobe, supplied more directly, remains enhanced when the
      portal-dependent anterior territory does not.
    evidence:
    - reference: PMID:24162077
      reference_title: "A novel hook-shaped enhancement on contrast-enhanced sagittal magnetic resonance image in acute Sheehan's syndrome: a case report."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "The pituitary stalk, majority of the marginal zone of the anterior lobe, the anterior lobe just in front of the posterior lobe, and posterior lobe were well enhanced."
      explanation: >-
        Shows preserved posterior-lobe perfusion in the same gland and at the
        same time as the anterior infarct, which is the contrast this edge
        asserts.
  evidence:
  - reference: PMID:24917653
    reference_title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Furthermore, small sella size may have an important contributing role in the etiopathogenesis of SS."
    explanation: >-
      Case-control sella volumetry supporting fixed sellar volume as a
      predisposing anatomical factor.
  - reference: PMID:24162077
    reference_title: "A novel hook-shaped enhancement on contrast-enhanced sagittal magnetic resonance image in acute Sheehan's syndrome: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The characteristic hook-shaped enhancement in Sheehan's syndrome well reflected the vulnerability to massive bleeding based on the complex pituitary vasculature, which has not been reported previously."
    explanation: >-
      States that the pituitary's vascular architecture is what makes it
      vulnerable to massive bleeding.
  - reference: PMID:37772209
    reference_title: Adrenal Crisis in a Delayed Diagnosis of Sheehan Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Maternal gestational changes and adaptations include relative hyperplasia of the pituitary gland with minimal increase in blood supply to the hypothalamohypophyseal portal system due to increased blood flow being prioritized to reproductive organs."
    explanation: >-
      States the mismatch this node models: the gland grows while its portal
      inflow does not keep pace.
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Little changes in blood flow can lead to ischemia of the pituitary gland."
    explanation: >-
      States the low perfusion reserve that is the substance of this node.
- name: Postpartum Haemorrhage with Hypovolaemia and Portal Vasospasm
  role: trigger
  biological_scale: ORGANISM
  description: >-
    Massive obstetric haemorrhage produces systemic hypovolaemia and hypotension;
    vasospasm of the hypothalamic portal vessels, and in some patients
    pregnancy-associated or inherited thrombotic tendency, further reduce inflow
    to the anterior lobe.
  downstream:
  - target: Ischaemic Infarction and Necrosis of the Anterior Pituitary
    causal_link_type: DIRECT
    description: >-
      Loss of perfusion pressure across the portal supply is the proximate cause
      of anterior-lobe infarction.
    evidence:
    - reference: PMID:36742387
      reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "It is primarily caused by vasospasm of hypothalamic portal vessels following massive postpartum hemorrhage (PPH), resulting in complete or partial loss of anterior pituitary gland cells."
      explanation: >-
        Names portal vasospasm after haemorrhage as the cause of anterior
        pituitary cell loss, which is exactly this edge.
  evidence:
  - reference: PMID:28004764
    reference_title: Sheehan syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Small sella turcica size, vasospasms (caused by PPH) and/or thrombosis (associated with pregnancy or coagulation disorders) are predisposing factors; autoimmunity might be involved in the progressive worsening of pituitary functions."
    explanation: >-
      Enumerates the haemodynamic and thrombotic contributors modelled by this
      node.
- name: Ischaemic Infarction and Necrosis of the Anterior Pituitary
  role: consequence
  biological_scale: TISSUE
  description: >-
    Sustained hypoperfusion of the portal-dependent anterior lobe produces
    ischaemic necrosis of the hormone-secreting cell populations. This is the
    defining lesion of the disease.
  locations:
  - preferred_term: anterior pituitary lobe
    term:
      id: UBERON:0002196
      label: adenohypophysis
  cell_types:
  - preferred_term: pituitary gland cell
    term:
      id: CL:2000004
      label: pituitary gland cell
  biological_processes:
  - preferred_term: cellular response to hypoxia
    term:
      id: GO:0071456
      label: cellular response to hypoxia
    modifier: INCREASED
  downstream:
  - target: Loss of Anterior Pituitary Trophic Hormone Secretion
    causal_link_type: DIRECT
    description: >-
      Destruction of the secretory cell populations removes their hormone output.
    evidence:
    - reference: PMID:28004764
      reference_title: Sheehan syndrome.
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Sheehan syndrome or postpartum hypopituitarism is a condition characterized by hypopituitarism due to necrosis of the pituitary gland."
      explanation: >-
        States that the hypopituitarism is caused by the necrosis, which is the
        claim this edge makes.
  - target: Progressive Pituitary Atrophy and Empty Sella Formation
    causal_link_type: DIRECT
    description: >-
      The infarcted lobe involutes over months to years, leaving a partially or
      completely empty sella.
    evidence:
    - reference: PMID:24162077
      reference_title: "A novel hook-shaped enhancement on contrast-enhanced sagittal magnetic resonance image in acute Sheehan's syndrome: a case report."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Follow-up MR image revealed marked atrophy of the anterior lobe."
      explanation: >-
        Follow-up imaging in the same patient shows the infarcted lobe
        progressing to atrophy.
  evidence:
  - reference: PMID:42175518
    reference_title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Sheehan syndrome is a rare but potentially fatal cause of hypopituitarism resulting from ischemic necrosis of the anterior pituitary following severe postpartum hemorrhage."
    explanation: >-
      States the defining lesion modelled by this node.
- name: Relative Preservation of Posterior Pituitary Perfusion
  role: modifier
  biological_scale: TISSUE
  description: >-
    Because the neurohypophysis is supplied more directly than the
    portal-dependent anterior lobe, it is comparatively spared, and clinically
    overt central diabetes insipidus is not part of the usual presentation. The
    sparing is relative rather than absolute: formal water-deprivation testing
    detects partial neurohypophyseal impairment in a substantial minority of
    patients who have no symptoms of diabetes insipidus, and rare cases present
    with overt central diabetes insipidus.
  locations:
  - preferred_term: posterior pituitary lobe
    term:
      id: UBERON:0002198
      label: neurohypophysis
  evidence:
  - reference: PMID:18230820
    reference_title: "Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "None of them had clinical central diabetes insipidus."
    explanation: >-
      In a cohort of 20 women with long-standing Sheehan syndrome, none had
      clinical diabetes insipidus, supporting relative posterior-lobe sparing.
  - reference: PMID:17468192
    reference_title: "Posterior pituitary function in Sheehan's syndrome."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "Our findings demonstrated that patients with Sheehan's syndrome have an impairment of neurohypophyseal function."
    explanation: >-
      Formal testing contradicts a strong reading of posterior-lobe sparing:
      neurohypophyseal function is measurably impaired even when patients are
      asymptomatic. Recorded as REFUTE against the absolute claim so the
      qualification in this node's description is auditable.
  - reference: PMID:17468192
    reference_title: "Posterior pituitary function in Sheehan's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "According to dehydration test, 8 (29.6%) patients had partial diabetes insipidus (PDI group) and 19 (70.3%) had normal response (non-DI group)."
    explanation: >-
      Quantifies the sparing: about 70% of tested patients had a normal
      water-deprivation response and the remainder had only partial impairment.
- name: Loss of Anterior Pituitary Trophic Hormone Secretion
  role: consequence
  biological_scale: ORGANISM
  description: >-
    Necrosis removes trophic hormone output in a characteristic order that tracks
    the position of each cell type relative to the vasculature: prolactin and
    growth hormone secretion are lost first and most often, then the
    gonadotropins, and only with more extensive necrosis thyroid-stimulating
    hormone and adrenocorticotropic hormone. Deficiency may be partial at
    presentation and accumulate over subsequent years.
  locations:
  - preferred_term: anterior pituitary lobe
    term:
      id: UBERON:0002196
      label: adenohypophysis
  downstream:
  - target: Prolactin Deficiency
    causal_link_type: DIRECT
  - target: Growth Hormone Deficiency
    causal_link_type: DIRECT
  - target: Gonadotropin Deficiency
    causal_link_type: DIRECT
  - target: Central Hypothyroidism from Thyroid-Stimulating Hormone Deficiency
    causal_link_type: DIRECT
  - target: Secondary Adrenal Insufficiency from Corticotropin Deficiency
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:28004764
    reference_title: Sheehan syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "In accordance with the location of hormone-secreting cells relative to the vasculature, the secretion of growth hormone and prolactin is most commonly affected, followed by follicle-stimulating hormone and luteinizing hormone; severe necrosis of the pituitary gland also affects the secretion of thyroid-stimulating hormone and adrenocorticotropic hormone."
    explanation: >-
      States both the ordering of axis loss and its vascular-anatomical basis.
  - reference: PMID:36243797
    reference_title: "Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Multiple (≥ 2) hormone deficiencies were present in 68.8% of patients, with hypothyroidism (91.4%), hypocortisolism (88.3%), and growth hormone (GH) deficiency (85.7%) being the most common."
    explanation: >-
      Quantifies multi-axis involvement in a 60-patient Sheehan syndrome cohort.
- name: Prolactin Deficiency
  role: consequence
  biological_scale: ORGANISM
  description: >-
    Loss of lactotrophs abolishes the prolactin surge required to initiate
    lactation. Because it presents immediately after the index delivery, it is
    the earliest available clinical clue.
  cell_types:
  - preferred_term: lactotroph
    term:
      id: CL:0000439
      label: prolactin secreting cell
  biological_processes:
  - preferred_term: prolactin secretion
    term:
      id: GO:0070459
      label: prolactin secretion
    modifier: DECREASED
  downstream:
  - target: Failure of Postpartum Lactation
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:24917653
    reference_title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "None of the patients whose basal prolactin was below 4.0 ng/ml had adequate prolactin responses to TRH test, while all patients whose basal prolactin was above 7.8 ng/ml had adequate responses."
    explanation: >-
      Documents deficient lactotroph reserve on dynamic testing in this cohort.
- name: Growth Hormone Deficiency
  role: consequence
  biological_scale: ORGANISM
  description: >-
    Somatotroph loss occurs in nearly all patients and is unusually severe in
    Sheehan syndrome compared with hypopituitarism of other causes. It is the
    principal driver of the adverse body-composition, lipid and hepatic
    phenotype that persists even on adequate glucocorticoid and thyroid
    replacement.
  cell_types:
  - preferred_term: somatotroph
    term:
      id: CL:0002312
      label: somatotroph
  biological_processes:
  - preferred_term: growth hormone secretion
    term:
      id: GO:0030252
      label: growth hormone secretion
    modifier: DECREASED
  downstream:
  - target: Hepatic Steatosis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Growth hormone deficiency is a predictor of hepatic steatosis in Sheehan
      syndrome cohorts.
    evidence:
    - reference: PMID:36243797
      reference_title: "Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "At a mean follow-up of 9.8 ± 6.8 years, NAFLD was present in 63% of patients, with 51% having severe steatosis, which was predicted by the presence of GH deficiency and higher body mass index."
      explanation: >-
        Names GH deficiency as a predictor of steatosis in this cohort, which is
        the claim this edge makes.
  - target: Increased Body Fat with Abdominal Predominance
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Growth hormone deficiency is named as the predominant contributor to the
      abdominal fat deposition that persists on other replacement.
    evidence:
    - reference: PMID:36742387
      reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "GH/IGF-1 deficiency appears to be the predominant contributor for abdominal obesity in such patients."
      explanation: >-
        Attributes the abdominal obesity of these patients principally to
        GH/IGF-1 deficiency, which is the claim this edge makes.
  - target: Atherogenic Dyslipidemia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      The persistent adverse lipid profile is attributed to unreplaced growth
      hormone deficiency rather than to inadequate thyroid or glucocorticoid
      replacement.
    evidence:
    - reference: PMID:36742387
      reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "These lipid abnormalities are attributed to persistent GHD"
      explanation: >-
        States the attribution of the lipid abnormalities to persistent growth
        hormone deficiency.
  - target: Insulin Resistance
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Untreated growth hormone deficiency is described as driving insulin
      resistance in hypopituitary patients who are otherwise adequately
      replaced.
    evidence:
    - reference: PMID:36742387
      reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Untreated GH deficiency (GHD) leading to IR, dyslipidemia and ED is the primary driver of increased CV mortality in hypopituitary subjects, who are adequately replaced with GC, thyroid and sex hormones"
      explanation: >-
        Names untreated growth hormone deficiency as what leads to insulin
        resistance in adequately replaced hypopituitary patients. The sentence
        is about hypopituitary subjects in general rather than Sheehan syndrome
        specifically, so this edge is INDIRECT_KNOWN_INTERMEDIATES.
  - target: Metabolic Syndrome
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      The composite metabolic syndrome is attributed jointly to growth hormone
      deficiency, glucocorticoid therapy and hypogonadism, so this edge carries
      only part of the causation.
    evidence:
    - reference: PMID:36742387
      reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Most of these abnormalities are a consequence of GHD, GC therapy and hypogonadism, all these factors favour abdominal fat deposition and atherogenic dyslipidemia."
      explanation: >-
        Names growth hormone deficiency first among the three contributors to
        the metabolic syndrome constituents, and names the other two, which is
        why this edge is not marked DIRECT.
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Somatotroph and thyrotroph cell loss occurs in almost all patients, with preservation or recovery of gonadotroph, lactotroph, and corticotroph cell function in few"
    explanation: >-
      States that somatotroph loss is near universal in Sheehan syndrome.
- name: Gonadotropin Deficiency
  role: consequence
  biological_scale: ORGANISM
  description: >-
    Loss of luteinizing hormone and follicle-stimulating hormone secretion
    prevents resumption of menstrual cycles after the puerperium and produces
    hypogonadotropic hypogonadism with loss of secondary sexual hair.
  cell_types:
  - preferred_term: gonadotroph
    term:
      id: CL:0000437
      label: gonadtroph
  biological_processes:
  - preferred_term: gonadotropin secretion
    term:
      id: GO:0032274
      label: gonadotropin secretion
    modifier: DECREASED
  downstream:
  - target: Secondary Amenorrhoea
    causal_link_type: DIRECT
  - target: Loss of Axillary and Pubic Hair
    causal_link_type: DIRECT
  - target: Osteoporosis
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      The long untreated hypogonadism created by the diagnostic delay is the
      principal driver of bone loss, with the other unreplaced axes and
      non-physiological replacement dosing contributing.
    evidence:
    - reference: PMID:39863703
      reference_title: "Sheehan syndrome: a current approach to a dormant disease."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: "Besides hypogonadotropic hypogonadism, other pituitary hormone deficiencies and inefficient or over replacement of deficient hormones all might play a role in the pathogenesis of decreased bone mass."
      explanation: >-
        Places hypogonadotropic hypogonadism first in the pathogenesis of
        decreased bone mass while naming the co-contributors, which is why this
        edge is not marked DIRECT.
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A comprehensive endocrine evaluation revealed secondary adrenal insufficiency, central hypothyroidism, and hypogonadotropic hypogonadism, as evidenced by low levels of ACTH, cortisol, TSH, free T4, FSH, LH, and prolactin."
    explanation: >-
      Documents biochemically confirmed hypogonadotropic hypogonadism in Sheehan
      syndrome.
- name: Central Hypothyroidism from Thyroid-Stimulating Hormone Deficiency
  role: consequence
  biological_scale: ORGANISM
  conforms_to: "hypothyroidism_thyroid_hormone_deficiency#Impaired Thyroid Hormone Synthesis"
  description: >-
    Thyrotroph loss removes the pituitary drive to the thyroid, so thyroid
    hormone synthesis falls without the compensatory rise in thyroid-stimulating
    hormone that characterises primary hypothyroidism. This node substitutes the
    disorder-specific lesion, central thyroid-stimulating hormone deficiency, for
    the module's generic impairment of thyroid hormone synthesis.
  cell_types:
  - preferred_term: thyrotroph
    term:
      id: CL:0000476
      label: thyrotroph
  - preferred_term: thyroid follicular cell
    term:
      id: CL:0002258
      label: thyroid follicular cell
  biological_processes:
  - preferred_term: thyroid-stimulating hormone secretion
    term:
      id: GO:0070460
      label: thyroid-stimulating hormone secretion
    modifier: DECREASED
  - preferred_term: thyroid hormone generation
    term:
      id: GO:0006590
      label: thyroid hormone generation
    modifier: DECREASED
  downstream:
  - target: Reduced Thyroid Hormone Action and Hypometabolism
    causal_link_type: DIRECT
  evidence:
  - reference: PMID:42175518
    reference_title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Laboratory investigations demonstrated microcytic hypochromic anemia, leukocytosis with neutrophilia, hyponatremia, markedly low morning cortisol (0.6 µg/dL), low FT3 and FT4, and low-normal TSH, consistent with panhypopituitarism."
    explanation: >-
      The combination of low free thyroid hormones with a low-normal rather than
      elevated TSH is the biochemical signature of the central lesion modelled
      here.
- name: Reduced Thyroid Hormone Action and Hypometabolism
  role: consequence
  biological_scale: ORGANISM
  conforms_to: "hypothyroidism_thyroid_hormone_deficiency#Reduced Thyroid Hormone Action at Peripheral Sites"
  description: >-
    Diminished circulating thyroid hormone lowers thyroid hormone action at
    peripheral target tissues, producing the hypometabolic symptom set shared
    with hypothyroidism of any cause.
  biological_processes:
  - preferred_term: response to thyroid hormone
    term:
      id: GO:0097066
      label: response to thyroid hormone
    modifier: DECREASED
  - preferred_term: regulation of metabolic process
    term:
      id: GO:0019222
      label: regulation of metabolic process
    modifier: DECREASED
  downstream:
  - target: Cold Intolerance
    causal_link_type: DIRECT
  - target: Chronic Fatigue
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The major clinical features of typical and complete SS include lactation failure, failure of resumption of menstrual cycles after the puerperium, loss of pubic and axillary hair, symptoms of hypothyroidism, and hypocortisolism"
    explanation: >-
      Lists symptomatic hypothyroidism among the core clinical features of the
      disease, which is the peripheral consequence modelled here.
- name: Secondary Adrenal Insufficiency from Corticotropin Deficiency
  role: consequence
  biological_scale: ORGANISM
  description: >-
    Corticotroph loss removes adrenocorticotropic hormone drive to the adrenal
    cortex. Because it usually requires more extensive necrosis, it appears later
    than prolactin and gonadotropin loss, but it is the deficiency that makes the
    disease lethal: an intercurrent illness in an unreplaced patient can
    precipitate adrenal crisis.
  cell_types:
  - preferred_term: corticotroph
    term:
      id: CL:0002309
      label: corticotroph
  biological_processes:
  - preferred_term: corticotropin secretion
    term:
      id: GO:0051458
      label: corticotropin secretion
    modifier: DECREASED
  downstream:
  - target: Adrenal Crisis
    causal_link_type: DIRECT
  - target: Hyponatraemia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  - target: Hypoglycaemia
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  evidence:
  - reference: PMID:24917653
    reference_title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It was found that 52.6% of patients had nonspecific complaints, 30.7% had complaints related to adrenal insufficiency, and 9.6% had complaints related to hypogonadism when diagnosed."
    explanation: >-
      Nearly a third of this cohort presented with adrenal-insufficiency
      complaints, supporting corticotroph failure as a major clinical outcome.
- name: Progressive Pituitary Atrophy and Empty Sella Formation
  role: consequence
  biological_scale: TISSUE
  description: >-
    Over months to years the infarcted gland involutes, and cerebrospinal fluid
    fills the sella, producing the partial or complete empty sella seen on MRI in
    long-standing disease. This is a radiological consequence of the index
    infarct, not an independent lesion.
  locations:
  - preferred_term: sella turcica
    term:
      id: UBERON:0003689
      label: sella turcica
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Magnetic resonance imaging (MRI) confirmed partial empty sella, supporting the diagnosis of SS."
    explanation: >-
      Documents the empty sella as the chronic-phase imaging finding used to
      support the diagnosis. The corresponding imaging_findings entry records
      the radiological observation itself.
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "In the end, a fibrous scar replaces the necrotic pituitary by time leading to empty sella appearence radiologically."
    explanation: >-
      States the tissue process, fibrous replacement of necrotic gland, that
      produces the empty sella modelled by this node.
phenotypes:
- category: Endocrine
  name: Failure of Postpartum Lactation
  frequency: VERY_FREQUENT
  description: >-
    Inability to initiate breastfeeding after the index delivery, the earliest
    and most specific clue to the diagnosis.
  phenotype_term:
    preferred_term: failure of postpartum lactation
    term:
      id: HP:0031109
      label: Agalactia
  diagnostic: true
  evidence:
  - reference: PMID:28004764
    reference_title: Sheehan syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Symptoms are caused by a decrease or absence of one or more of the pituitary hormones, and vary, among others, from failure to lactate and nonspecific symptoms (such as fatigue) to severe adrenal crisis."
    explanation: >-
      Names failure to lactate as a presenting manifestation of the hormone
      deficiency.
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The major clinical features of typical and complete SS include lactation failure, failure of resumption of menstrual cycles after the puerperium, loss of pubic and axillary hair, symptoms of hypothyroidism, and hypocortisolism"
    explanation: >-
      Lists lactation failure first among the major clinical features,
      supporting the VERY_FREQUENT band.
- category: Endocrine
  name: Secondary Amenorrhoea
  frequency: VERY_FREQUENT
  description: >-
    Failure of menstrual cycles to resume after the puerperium, due to
    gonadotropin deficiency.
  phenotype_term:
    preferred_term: secondary amenorrhoea
    term:
      id: HP:0000869
      label: Secondary amenorrhea
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The major clinical features of typical and complete SS include lactation failure, failure of resumption of menstrual cycles after the puerperium, loss of pubic and axillary hair, symptoms of hypothyroidism, and hypocortisolism"
    explanation: >-
      Names failure to resume menses among the major clinical features.
- category: Endocrine
  name: Hypogonadotropic Hypogonadism
  description: >-
    Low gonadotropins with low sex steroids, confirmed biochemically.
  phenotype_term:
    preferred_term: hypogonadotropic hypogonadism
    term:
      id: HP:0000044
      label: Hypogonadotropic hypogonadism
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A comprehensive endocrine evaluation revealed secondary adrenal insufficiency, central hypothyroidism, and hypogonadotropic hypogonadism, as evidenced by low levels of ACTH, cortisol, TSH, free T4, FSH, LH, and prolactin."
    explanation: >-
      Reports the biochemically confirmed hypogonadotropic hypogonadism.
- category: Integumentary
  name: Loss of Axillary and Pubic Hair
  description: >-
    Loss of secondary sexual hair, reflecting combined gonadotropin and
    corticotropin deficiency.
  phenotype_term:
    preferred_term: loss of axillary hair
    term:
      id: HP:0002221
      label: Absent axillary hair
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The major clinical features of typical and complete SS include lactation failure, failure of resumption of menstrual cycles after the puerperium, loss of pubic and axillary hair, symptoms of hypothyroidism, and hypocortisolism"
    explanation: >-
      Names loss of pubic and axillary hair among the major clinical features.
- category: Endocrine
  name: Central Hypothyroidism
  frequency: VERY_FREQUENT
  description: >-
    Low free thyroid hormones with an inappropriately low or normal
    thyroid-stimulating hormone.
  phenotype_term:
    preferred_term: pituitary hypothyroidism
    term:
      id: HP:0008245
      label: Pituitary hypothyroidism
  evidence:
  - reference: PMID:36243797
    reference_title: "Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Multiple (≥ 2) hormone deficiencies were present in 68.8% of patients, with hypothyroidism (91.4%), hypocortisolism (88.3%), and growth hormone (GH) deficiency (85.7%) being the most common."
    explanation: >-
      Reports hypothyroidism in 91.4% of a 60-patient Sheehan syndrome cohort,
      supporting the VERY_FREQUENT band.
- category: Endocrine
  name: Secondary Adrenal Insufficiency
  frequency: VERY_FREQUENT
  description: >-
    Cortisol deficiency due to loss of adrenocorticotropic hormone drive.
  phenotype_term:
    preferred_term: adrenocorticotropin deficient adrenal insufficiency
    term:
      id: HP:0011735
      label: Adrenocorticotropin deficient adrenal insufficiency
  evidence:
  - reference: PMID:36243797
    reference_title: "Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Multiple (≥ 2) hormone deficiencies were present in 68.8% of patients, with hypothyroidism (91.4%), hypocortisolism (88.3%), and growth hormone (GH) deficiency (85.7%) being the most common."
    explanation: >-
      Reports hypocortisolism in 88.3% of this cohort.
- category: Endocrine
  name: Adrenal Crisis
  description: >-
    Acute, life-threatening decompensation of unreplaced or under-replaced
    cortisol deficiency, typically precipitated by intercurrent illness,
    infection, surgery or pregnancy. In a substantial minority of patients it is
    the event that finally prompts the diagnosis.
  phenotype_term:
    preferred_term: adrenal crisis
    term:
      id: HP:0000846
      label: Adrenal insufficiency
    temporality: ACUTE
  severity: SEVERE
  evidence:
  - reference: PMID:42175518
    reference_title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Because symptoms often develop gradually and nonspecifically, diagnosis is frequently delayed until acute illness precipitates adrenal crisis or severe hypoglycemia."
    explanation: >-
      States that acute illness precipitating adrenal crisis is a common route
      to diagnosis.
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "She developed an adrenal crisis during pregnancy, which was managed through hydrocortisone dose modification."
    explanation: >-
      Documents an adrenal crisis occurring in a diagnosed and replaced patient
      under physiological stress.
  sequelae:
  - target: Hyponatraemia
    description: >-
      Cortisol deficiency impairs free-water excretion, producing hyponatraemia
      during decompensation.
- category: Metabolic
  name: Hyponatraemia
  description: >-
    Low serum sodium, a common laboratory finding at presentation and during
    adrenal decompensation.
  phenotype_term:
    preferred_term: hyponatraemia
    term:
      id: HP:0002902
      label: Hyponatremia
  evidence:
  - reference: PMID:42175518
    reference_title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Laboratory investigations demonstrated microcytic hypochromic anemia, leukocytosis with neutrophilia, hyponatremia, markedly low morning cortisol (0.6 µg/dL), low FT3 and FT4, and low-normal TSH, consistent with panhypopituitarism."
    explanation: >-
      Reports hyponatraemia in a patient presenting with Sheehan syndrome.
- category: Metabolic
  name: Hypoglycaemia
  description: >-
    Recurrent hypoglycaemia, reflecting the loss of the counter-regulatory
    actions of cortisol and growth hormone.
  phenotype_term:
    preferred_term: hypoglycaemia
    term:
      id: HP:0001943
      label: Hypoglycemia
  evidence:
  - reference: PMID:42175518
    reference_title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "A 48-year-old woman presented with central chest pain, productive cough, dyspnea, intermittent fever, severe anemia, and recurrent hypoglycemia."
    explanation: >-
      Reports recurrent hypoglycaemia as a presenting feature.
- category: Constitutional
  name: Chronic Fatigue
  frequency: VERY_FREQUENT
  description: >-
    Long-standing, non-specific fatigue and generalised body aches. This is the
    dominant symptom in the latent phase and the principal reason the diagnosis
    is missed.
  phenotype_term:
    preferred_term: chronic fatigue
    term:
      id: HP:0012432
      label: Chronic fatigue
    temporality: CHRONIC
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "SS presents with long-standing non-specific symptoms of fatigue and generalized body aches."
    explanation: >-
      States that long-standing non-specific fatigue is the typical
      presentation.
  - reference: PMID:24917653
    reference_title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "It was found that 52.6% of patients had nonspecific complaints, 30.7% had complaints related to adrenal insufficiency, and 9.6% had complaints related to hypogonadism when diagnosed."
    explanation: >-
      More than half of this cohort presented with non-specific complaints,
      supporting the VERY_FREQUENT band.
- category: Constitutional
  name: Cold Intolerance
  description: >-
    Reduced tolerance of cold, a hypometabolic consequence of central
    hypothyroidism.
  phenotype_term:
    preferred_term: cold intolerance
    term:
      id: HP:6000855
      label: Cold intolerance
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals may present with signs and symptoms including weight gain or loss, cold intolerance, hair loss, menstrual irregularities, and hypotension."
    explanation: >-
      Lists cold intolerance among the presenting features of the syndrome.
- category: Cardiovascular
  name: Hypotension
  description: >-
    Low blood pressure, reflecting cortisol deficiency.
  phenotype_term:
    preferred_term: hypotension
    term:
      id: HP:0002615
      label: Hypotension
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Affected individuals may present with signs and symptoms including weight gain or loss, cold intolerance, hair loss, menstrual irregularities, and hypotension."
    explanation: >-
      Lists hypotension among the presenting features of the syndrome.
- category: Endocrine
  name: Growth Hormone Deficiency
  frequency: VERY_FREQUENT
  description: >-
    Acquired, typically severe growth hormone deficiency, which persists as a
    driver of adverse body composition and lipid profile after other axes are
    replaced.
  phenotype_term:
    preferred_term: secondary growth hormone deficiency
    term:
      id: HP:0008240
      label: Secondary growth hormone deficiency
  evidence:
  - reference: PMID:36243797
    reference_title: "Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Multiple (≥ 2) hormone deficiencies were present in 68.8% of patients, with hypothyroidism (91.4%), hypocortisolism (88.3%), and growth hormone (GH) deficiency (85.7%) being the most common."
    explanation: >-
      Reports growth hormone deficiency in 85.7% of this cohort.
- category: Hepatic
  name: Hepatic Steatosis
  frequency: FREQUENT
  description: >-
    Non-alcoholic fatty liver disease, frequently severe, attributed largely to
    untreated growth hormone deficiency.
  phenotype_term:
    preferred_term: hepatic steatosis
    term:
      id: HP:0001397
      label: Hepatic steatosis
  evidence:
  - reference: PMID:36243797
    reference_title: "Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "At a mean follow-up of 9.8 ± 6.8 years, NAFLD was present in 63% of patients, with 51% having severe steatosis, which was predicted by the presence of GH deficiency and higher body mass index."
    explanation: >-
      Reports NAFLD in 63% of patients at long-term follow-up, supporting the
      FREQUENT band.
- category: Metabolic
  name: Metabolic Syndrome
  frequency: FREQUENT
  description: >-
    The composite metabolic syndrome is present in around half of patients, its
    dominant constituents being increased waist circumference, low
    high-density-lipoprotein cholesterol and raised triglycerides. Those
    constituents are curated separately below; this entry records the composite
    diagnosis and its reported prevalence.
  phenotype_term:
    preferred_term: metabolic syndrome
    term:
      id: MONDO:0000816
      label: abdominal obesity-metabolic syndrome
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The prevalence of MS in SS is around 50% with major constituents being increased WC, decreased HDL-C and increased TG."
    explanation: >-
      States the prevalence of metabolic syndrome in Sheehan syndrome as around
      50%, which is the basis for the FREQUENT band, and names its constituents.
- category: Metabolic
  name: Increased Body Fat with Abdominal Predominance
  description: >-
    Increased body mass index and total body fat with a predominantly abdominal
    distribution, which persists after thyroxine and glucocorticoid replacement.
  phenotype_term:
    preferred_term: abdominal obesity
    term:
      id: HP:0012743
      label: Abdominal obesity
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "patients with SS in comparison to age and gender matched population have increased body mass index (BMI) and total body fat with predominant abdominal fat deposition"
    explanation: >-
      States the increase in total body fat and its abdominal predominance
      relative to matched controls.
- category: Metabolic
  name: Atherogenic Dyslipidemia
  description: >-
    A combined lipid abnormality - raised total cholesterol,
    low-density-lipoprotein cholesterol and triglycerides with low
    high-density-lipoprotein cholesterol - that persists despite adequate
    thyroxine and glucocorticoid replacement. The term is bound at the level of
    abnormal circulating lipid concentration because the claim spans changes in
    both directions, which no single narrower HPO term covers.
  phenotype_term:
    preferred_term: atherogenic dyslipidemia
    term:
      id: HP:0003119
      label: Abnormal circulating lipid concentration
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Inspite of thyroxine and GC replacement, patients with SS have adverse lipid parameters like increased serum total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and triglycerides (TG) and low high density lipoprotein cholesterol (HDL-C)."
    explanation: >-
      Names each of the four lipid changes and states that they persist on
      thyroid and glucocorticoid replacement.
- category: Metabolic
  name: Insulin Resistance
  description: >-
    Insulin resistance measured as an elevated homeostasis model assessment
    index relative to healthy controls.
  phenotype_term:
    preferred_term: insulin resistance
    term:
      id: HP:0000855
      label: Insulin resistance
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Homeostasis model assessment-insulin resistance (HOMA-IR), an index of IR was high in large group of women with SS compared to healthy controls"
    explanation: >-
      Reports HOMA-IR as high in women with Sheehan syndrome compared with
      healthy controls, which is the measurement behind this phenotype.
  sequelae:
  - target: Diabetes Mellitus
    description: >-
      Insulin resistance with raised fasting and post-meal glucose progresses to
      frank diabetes in a substantial minority of patients.
- category: Metabolic
  name: Diabetes Mellitus
  frequency: OCCASIONAL
  description: >-
    Frank diabetes mellitus, reported in around a quarter of patients, alongside
    raised fasting and post-meal glucose values.
  phenotype_term:
    preferred_term: diabetes mellitus
    term:
      id: HP:0000819
      label: Diabetes mellitus
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Around one fourth of patients with SS had diabetes mellitus"
    explanation: >-
      Gives the approximately one-in-four figure that the OCCASIONAL band is
      taken from.
- category: Musculoskeletal
  name: Osteoporosis
  frequency: FREQUENT
  description: >-
    Reduced bone mineral density progressing to osteoporosis, driven principally
    by the long period of untreated hypogonadism that the diagnostic delay
    creates, with contributions from the other unreplaced axes and from
    non-physiological glucocorticoid and thyroxine dosing.
  phenotype_term:
    preferred_term: osteoporosis
    term:
      id: HP:0000939
      label: Osteoporosis
  evidence:
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "In another study including 60 patients with SS, osteopenia was found to be present 41.7 and osteoporosis in 35.0% of the patients and bone mineral density (BMD) was found to be significantly lower compared to the control group."
    explanation: >-
      Reports osteoporosis in 35.0% of a 60-patient Sheehan syndrome cohort with
      bone mineral density significantly below matched controls, which is the
      basis for the FREQUENT band.
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Sheehan syndrome increases the risk of osteoporosis and osteopenia"
    explanation: >-
      States the association between the disease and osteoporosis directly.
- category: Hematologic
  name: Anaemia
  description: >-
    Anaemia is a recognised, less specific manifestation of the multi-axis
    hormone deficiency.
  phenotype_term:
    preferred_term: anaemia
    term:
      id: HP:0001903
      label: Anemia
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Less common manifestations of SS include hematological abnormalities (like anemia and pancytopenia), cardiac abnormalities (like cardiomyopathy and ventricular arrhythmias), and neuropsychiatric abnormalities (like psychosis)"
    explanation: >-
      Lists anaemia among the less common haematological manifestations.
imaging_findings:
- name: Empty Sella on Magnetic Resonance Imaging
  modality: MRI
  description: >-
    Partial or complete empty sella, the chronic-phase radiological correlate of
    anterior pituitary infarction and involution.
  imaging_finding_term:
    preferred_term: empty sella turcica
    term:
      id: HP:6000483
      label: Empty sella turcica
  located_in:
    preferred_term: sella turcica
    term:
      id: UBERON:0003689
      label: sella turcica
  diagnostic: true
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Magnetic resonance imaging (MRI) confirmed partial empty sella, supporting the diagnosis of SS."
    explanation: >-
      Reports the empty sella as a diagnostic imaging finding in Sheehan
      syndrome.
- name: Acute Anterior Lobe Swelling and Non-Enhancement
  modality: MRI
  description: >-
    In the acute phase, contrast-enhanced MRI shows a swollen anterior lobe with
    a non-enhancing central territory while the stalk, the marginal zone and the
    posterior lobe still enhance.
  located_in:
    preferred_term: anterior pituitary lobe
    term:
      id: UBERON:0002196
      label: adenohypophysis
  evidence:
  - reference: PMID:24162077
    reference_title: "A novel hook-shaped enhancement on contrast-enhanced sagittal magnetic resonance image in acute Sheehan's syndrome: a case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In contrast, the central portion and the superior margin, just in front of the stalk insertion of the anterior lobe, were not enhanced."
    explanation: >-
      Describes the non-enhancing infarcted territory that defines the acute
      imaging appearance.
diagnosis:
- name: Dynamic Prolactin Testing
  description: >-
    Basal prolactin plus a thyrotropin-releasing hormone stimulation test
    discriminates lactotroph reserve, and was reported to have high sensitivity
    and specificity for prolactin deficiency in Sheehan syndrome.
  evidence:
  - reference: PMID:24917653
    reference_title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In addition, the TRH stimulation test was found to have a high sensitivity and specificity to recognize PRL deficiency."
    explanation: >-
      States the diagnostic performance of the test in this cohort.
- name: Clinical Diagnosis on Obstetric History and Hormone Testing
  description: >-
    Diagnosis rests on the combination of a history of severe postpartum
    haemorrhage with basal hormone levels and, where needed, stimulation tests.
  evidence:
  - reference: PMID:28004764
    reference_title: Sheehan syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Diagnosis is based on clinical manifestations combined with a history of severe PPH; hormone levels and/or stimulation tests can confirm clinical suspicion."
    explanation: >-
      States the diagnostic approach.
differential_diagnoses:
- name: Lymphocytic hypophysitis
  description: >-
    Autoimmune hypophysitis also causes peripartum hypopituitarism, but it is
    not preceded by obstetric haemorrhage and typically shows a symmetrically
    enlarged, homogeneously enhancing gland with stalk thickening rather than an
    infarct progressing to an empty sella.
  distinguishing_features:
  - Absence of severe postpartum haemorrhage in the index pregnancy
  - Pituitary enlargement rather than infarction and later atrophy
  evidence:
  - reference: PMID:9880116
    reference_title: Pituitary diseases in pregnancy.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Hypopituitarism arising postpartum may be caused by either lymphocytic hypophysitis or Sheehan's syndrome, and the latter may present as an acute or chronic syndrome."
    explanation: >-
      Names lymphocytic hypophysitis as the alternative cause of postpartum
      hypopituitarism that must be distinguished.
- name: Postpartum depression
  description: >-
    The non-specific fatigue, low mood and weight change of untreated
    hypopituitarism are commonly attributed to postpartum depression, which is
    a principal reason for the long diagnostic delay.
  distinguishing_features:
  - Failure of lactation and failure to resume menses
  - Biochemical multi-axis pituitary hormone deficiency
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Diagnosis is often delayed due to its nonspecific presentation and overlap with conditions like postpartum depression and chronic fatigue syndrome."
    explanation: >-
      Names postpartum depression as the condition Sheehan syndrome is commonly
      mistaken for.
treatments:
- name: Lifelong Pituitary Hormone Replacement
  description: >-
    There is no way to restore the infarcted gland, so management is lifelong
    replacement of the deficient target hormones, adjusted for stress and
    reviewed as further axes fail.
  therapeutic_modality: OTHER
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: Hormone Replacement Therapy
    term:
      id: NCIT:C15599
      label: Hormone Replacement Therapy
  target_mechanisms:
  - target: Loss of Anterior Pituitary Trophic Hormone Secretion
    treatment_effect: BYPASSES
    description: >-
      Replacement supplies the target-gland hormones directly, bypassing the
      absent pituitary trophic drive.
  evidence:
  - reference: PMID:28004764
    reference_title: Sheehan syndrome.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Hormone replacement therapy is the only available management option so far."
    explanation: >-
      States that replacement is the only available management, which is the
      claim this treatment entry makes.
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "She was started on lifelong hormone replacement therapy (HRT) consisting of hydrocortisone, levothyroxine, and estrogen."
    explanation: >-
      Documents the composition of lifelong replacement in a treated patient.
- name: Glucocorticoid Replacement
  description: >-
    Hydrocortisone replacement for secondary adrenal insufficiency, with stress
    dosing during illness, surgery and pregnancy. Critically, glucocorticoid must
    be started BEFORE thyroid hormone: correcting hypothyroidism first raises
    metabolic clearance of the little cortisol that remains and can precipitate
    an adrenal crisis.
  therapeutic_modality: SMALL_MOLECULE
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: hydrocortisone
      term:
        id: CHEBI:17650
        label: cortisol
  target_phenotypes:
  - preferred_term: adrenocorticotropin deficient adrenal insufficiency
    term:
      id: HP:0011735
      label: Adrenocorticotropin deficient adrenal insufficiency
  target_mechanisms:
  - target: Secondary Adrenal Insufficiency from Corticotropin Deficiency
    treatment_effect: BYPASSES
    description: >-
      Exogenous glucocorticoid replaces the cortisol the adrenal cortex no longer
      makes without corticotropin drive.
  evidence:
  - reference: PMID:42175518
    reference_title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patient was started on oral glucocorticoid replacement with prednisolone 10 mg daily to address adrenal insufficiency, with plans for lifelong maintenance and stress-dose adjustments during periods of illness or surgery."
    explanation: >-
      Documents lifelong glucocorticoid replacement with stress dosing in a
      patient with Sheehan syndrome.
  - reference: PMID:42175518
    reference_title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "glucocorticoid replacement should always precede thyroid hormone initiation in suspected or confirmed adrenal insufficiency to avoid precipitating adrenal crisis"
    explanation: >-
      States the sequencing rule that makes this treatment ordering-critical,
      and the harm it prevents.
  - reference: PMID:37772209
    reference_title: Adrenal Crisis in a Delayed Diagnosis of Sheehan Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Without appropriate steroid supplementation exogenously, patients can rapidly decline with adverse hypotension, altered mental status, and loss of vascular tone."
    explanation: >-
      Describes the decompensation that follows interruption of glucocorticoid
      replacement, in a case where missed doses precipitated adrenal crisis.
  - reference: PMID:37772209
    reference_title: Adrenal Crisis in a Delayed Diagnosis of Sheehan Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "This case demonstrates a secondary etiology of adrenal insufficiency, where the steroid regimen utilized glucocorticoid and mineralocorticoid supplementation, but by understanding the pathophysiology, the mineralocorticoid supplementation was an additional and unnecessary course since physiological mineralocorticoid secretion is primarily influenced by adequate renal perfusion (i.e., renin-angiotensin pathway) and not directly associated with primary adrenal insufficiency"
    explanation: >-
      Supports restricting replacement to glucocorticoid: because the lesion is
      pituitary rather than adrenal, the mineralocorticoid axis is intact and
      fludrocortisone is not required.
- name: Levothyroxine Replacement
  description: >-
    Levothyroxine for central hypothyroidism, titrated on free thyroxine rather
    than thyroid-stimulating hormone because the pituitary feedback arm is the
    lesion. It must not be started before glucocorticoid replacement in a patient
    with suspected or confirmed adrenal insufficiency.
  therapeutic_modality: SMALL_MOLECULE
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: levothyroxine
      term:
        id: CHEBI:6446
        label: levothyroxine sodium anhydrous
  target_phenotypes:
  - preferred_term: pituitary hypothyroidism
    term:
      id: HP:0008245
      label: Pituitary hypothyroidism
  target_mechanisms:
  - target: Central Hypothyroidism from Thyroid-Stimulating Hormone Deficiency
    treatment_effect: BYPASSES
    description: >-
      Exogenous thyroxine replaces the hormone the thyroid no longer makes
      without thyroid-stimulating hormone drive.
  evidence:
  - reference: PMID:42175518
    reference_title: "A rare presentation of Sheehan's syndrome with recurrent hypoglycemia: A case report."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The patient was treated with glucocorticoid replacement therapy, followed by levothyroxine supplementation."
    explanation: >-
      Documents levothyroxine replacement given after, not before,
      glucocorticoid.
- name: Sex Steroid Replacement
  description: >-
    Oestrogen with progestogen for hypogonadotropic hypogonadism until the
    expected age of menopause, to relieve symptoms and limit bone loss. Fertility
    requires gonadotropin therapy rather than sex steroids.
  therapeutic_modality: SMALL_MOLECULE
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: Estrogen Replacement Therapy
    term:
      id: NCIT:C15231
      label: Estrogen Replacement Therapy
  target_phenotypes:
  - preferred_term: hypogonadotropic hypogonadism
    term:
      id: HP:0000044
      label: Hypogonadotropic hypogonadism
  target_mechanisms:
  - target: Gonadotropin Deficiency
    treatment_effect: BYPASSES
    description: >-
      Exogenous sex steroid replaces the ovarian output that absent gonadotropin
      drive no longer supports.
  evidence:
  - reference: PMID:41116860
    reference_title: "A Decade With Sheehan's Syndrome: A Case Report and Personal Experience."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Pregnancy was later achieved through ovulation induction using human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG)."
    explanation: >-
      Shows that sex steroid replacement does not restore fertility, which
      requires gonadotropin therapy instead.
- name: Growth Hormone Replacement
  description: >-
    Recombinant growth hormone added to standard replacement in selected
    patients, which improves the cardiometabolic profile that persists on
    glucocorticoid, thyroid and sex steroid replacement alone.
  therapeutic_modality: PROTEIN_REPLACEMENT
  action_category: THERAPEUTIC
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: somatropin
      term:
        id: NCIT:C837
        label: Somatropin
  target_phenotypes:
  - preferred_term: secondary growth hormone deficiency
    term:
      id: HP:0008240
      label: Secondary growth hormone deficiency
  - preferred_term: atherogenic dyslipidemia
    term:
      id: HP:0003119
      label: Abnormal circulating lipid concentration
  - preferred_term: abdominal obesity
    term:
      id: HP:0012743
      label: Abdominal obesity
  target_mechanisms:
  - target: Growth Hormone Deficiency
    treatment_effect: BYPASSES
    description: >-
      Recombinant growth hormone replaces the absent somatotroph output.
  evidence:
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Replacement with GH in addition to standard hormone replacement improves their cardiometabolic profile."
    explanation: >-
      States the benefit of adding growth hormone to standard replacement in
      this disease.
  - reference: PMID:36742387
    reference_title: "Sheehan syndrome: Cardiovascular and metabolic comorbidities."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "GH treatment had a favourable effect on CIMT, lipids and visceral fat."
    explanation: >-
      Names the lipid and visceral-fat improvements that connect this treatment
      to the dyslipidemia and abdominal-obesity phenotypes it targets.
discussions:
- discussion_id: sheehan-autoimmune-perpetuation
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Does an autoimmune response to pituitary and hypothalamic antigens released
    by the infarcted gland actively perpetuate and extend hormone loss in Sheehan
    syndrome, or are anti-pituitary and anti-hypothalamus antibodies a
    non-causal marker of the necrosis that has already occurred?
  attaches_to:
  - pathophysiology#Ischaemic Infarction and Necrosis of the Anterior Pituitary
  - pathophysiology#Loss of Anterior Pituitary Trophic Hormone Secretion
  rationale: >-
    Hormone deficiencies accumulate for years to decades after a single
    peripartum vascular insult, and a secondary autoimmune process against
    antigens released by the necrotic gland is the leading proposed explanation.
    Anti-pituitary antibodies are found in roughly a third of long-standing
    cases and anti-hypothalamus antibodies in about 40%, but these are
    cross-sectional associations in small cohorts with no demonstration that the
    antibodies precede the additional hormone loss or are pathogenic. Because the
    evidence does not establish direction, this entry does not draw a causal edge
    from autoimmunity to progressive hormone loss; the autoimmune contribution is
    recorded here as an open question instead. Resolving it matters clinically:
    if the process is active and antibody-mediated, antibody status might
    identify patients whose remaining axes are at risk, which nothing in current
    practice does.
  evidence:
  - reference: PMID:18230820
    reference_title: "Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "AHAs were found in 8 out of 20 (40%) and APAs in 7 out of 20 (35%) patients with titers ranging from 1:32 to 1:128 and 1:16 to 1:32 respectively; however, in none of these positive patients AHA immunostained vasopressin cells."
    explanation: >-
      Establishes that the antibodies are present in a substantial minority of
      patients, which is the observation the open question is about.
  - reference: PMID:18230820
    reference_title: "Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "Antibodies to unknown hypothalamic cells (releasing factor-secreting cells) other than APAs suggest that an autoimmune process involving both the hypothalamus and pituitary gland may contribute to late pituitary dysfunction in SS patients."
    explanation: >-
      The authors themselves phrase the causal contribution as a suggestion
      inferred from an association, not a demonstrated mechanism, which is why
      this is curated as a knowledge gap rather than a causal edge.
  - reference: PMID:28004764
    reference_title: Sheehan syndrome.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    snippet: "Small sella turcica size, vasospasms (caused by PPH) and/or thrombosis (associated with pregnancy or coagulation disorders) are predisposing factors; autoimmunity might be involved in the progressive worsening of pituitary functions."
    explanation: >-
      The primary review hedges the autoimmune contribution as "might be
      involved", in contrast to the predisposing factors it states outright.
  - reference: PMID:24917653
    reference_title: "Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: "The number of deficient hormones was found to be increased over the years."
    explanation: >-
      Establishes the progressive hormone loss that any perpetuating mechanism,
      autoimmune or otherwise, would have to explain.
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Following necrosis of the pituitary gland, autoimmunity may come to the scene either as a cause or consequence of development and deterioration of hypopituitarism"
    explanation: >-
      States the unresolved direction of the association explicitly, which is
      precisely the open question recorded here.
  - reference: PMID:39863703
    reference_title: "Sheehan syndrome: a current approach to a dormant disease."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: "On the other hand, in a prospective study, 20 pregnant women with postpartum hemorrhage were followed up for 6 months and hypopituitarism developed in 25% of them and none of the patients were positive for pituitary antibodies"
    explanation: >-
      A prospective cohort in which post-haemorrhage hypopituitarism developed
      without any detectable pituitary antibodies argues against an obligatory
      autoimmune step, and is the main reason this is curated as an open
      question rather than a causal edge. Graded HUMAN_CLINICAL because the
      review is reporting the design and result of a prospective patient cohort
      here rather than offering an expert synthesis.
review_notes: >-
  Curated de novo. Every snippet was checked against the local reference cache.
  The posterior-pituitary node deliberately carries one REFUTE item: formal
  water-deprivation testing shows measurable neurohypophyseal impairment, so the
  common statement that the posterior lobe is "spared" is true only in the
  relative, clinical sense recorded in that node's description.
  `just discover-datasets Sheehan_Syndrome` returned no GEO candidates, so the
  entry carries no `datasets:` block; this is the expected result for a
  non-genetic rare disease with no molecular assay literature, not an omission.

📚

References & Deep Research